Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Sang Wan Kim  (Kim SW) 43 Articles
Calcium & bone metabolism
Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality
Sung Hye Kong, Jeong Mo Bae, Jung Hee Kim, Sang Wan Kim, Dohyun Han, Chan Soo Shin
Endocrinol Metab. 2024;39(2):375-386.   Published online March 21, 2024
DOI: https://doi.org/10.3803/EnM.2023.1827
  • 1,009 View
  • 20 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Parathyroid adenoma (PA) is a common endocrine disease linked to multiple complications, but the pathophysiology of the disease remains incompletely understood. The study aimed to identify the key regulator proteins and pathways of PA according to functionality and volume through quantitative proteomic analyses.
Methods
We conducted a retrospective study of 15 formalin-fixed, paraffin-embedded PA samples from tertiary hospitals in South Korea. Proteins were extracted, digested, and the resulting peptides were analyzed using liquid chromatography-tandem mass spectrometry. Pearson correlation analysis was employed to identify proteins significantly correlated with clinical variables. Canonical pathways and transcription factors were analyzed using Ingenuity Pathway Analysis.
Results
The median age of the participants was 52 years, and 60.0% were female. Among the 8,153 protein groups analyzed, 496 showed significant positive correlations with adenoma volume, while 431 proteins were significantly correlated with parathyroid hormone (PTH) levels. The proteins SLC12A9, LGALS3, and CARM1 were positively correlated with adenoma volume, while HSP90AB2P, HLA-DRA, and SCD5 showed negative correlations. DCPS, IRF2BPL, and FAM98A were the main proteins that exhibited positive correlations with PTH levels, and SLITRK4, LAP3, and AP4E1 had negative correlations. Canonical pathway analysis demonstrated that the RAN and sirtuin signaling pathways were positively correlated with both PTH levels and adenoma volume, while epithelial adherence junction pathways had negative correlations.
Conclusion
Our study identified pivotal proteins and pathways associated with PA, offering potential therapeutic targets. These findings accentuate the importance of proteomics in understanding disease pathophysiology and the need for further research.
Close layer
Calcium & bone metabolism
Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
Kyoung Jin Kim, Jeonghoon Ha, Sang Wan Kim, Jung-Eun Kim, Sihoon Lee, Han Seok Choi, Namki Hong, Sung Hye Kong, Seong Hee Ahn, So Young Park, Ki-Hyun Baek, on Behalf of Metabolic Bone Disease Study Group of Korean Endocrine Society
Endocrinol Metab. 2024;39(2):267-282.   Published online April 25, 2024
DOI: https://doi.org/10.3803/EnM.2024.1939
  • 321 View
  • 17 Download
AbstractAbstract PDFPubReader   ePub   
This review article investigates solid organ transplantation-induced osteoporosis, a critical yet often overlooked issue, emphasizing its significance in post-transplant care. The initial sections provide a comprehensive understanding of the prevalence and multifactorial pathogenesis of transplantation osteoporosis, including factors such as deteriorating post-transplantation health, hormonal changes, and the impact of immunosuppressive medications. Furthermore, the review is dedicated to organ-specific considerations in transplantation osteoporosis, with separate analyses for kidney, liver, heart, and lung transplantations. Each section elucidates the unique challenges and management strategies pertinent to transplantation osteoporosis in relation to each organ type, highlighting the necessity of an organ-specific approach to fully understand the diverse manifestations and implications of transplantation osteoporosis. This review underscores the importance of this topic in transplant medicine, aiming to enhance awareness and knowledge among clinicians and researchers. By comprehensively examining transplantation osteoporosis, this study contributes to the development of improved management and care strategies, ultimately leading to improved patient outcomes in this vulnerable group. This detailed review serves as an essential resource for those involved in the complex multidisciplinary care of transplant recipients.
Close layer
Adrenal Gland
Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary Aldosteronism (Endocrinol Metab 2021;36:875-84, Ye Seul Yang et al.)
Ye Seul Yang, Sang Wan Kim
Endocrinol Metab. 2022;37(6):953-954.   Published online December 12, 2022
DOI: https://doi.org/10.3803/EnM.2022.603
[Original]
  • 1,386 View
  • 151 Download
PDFPubReader   ePub   
Close layer
Adrenal Gland
Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism
Jung Hee Kim, Chang Ho Ahn, Su Jin Kim, Kyu Eun Lee, Jong Woo Kim, Hyun-Ki Yoon, Yu-Mi Lee, Tae-Yon Sung, Sang Wan Kim, Chan Soo Shin, Jung-Min Koh, Seung Hun Lee
Endocrinol Metab. 2022;37(2):369-382.   Published online April 14, 2022
DOI: https://doi.org/10.3803/EnM.2022.1391
  • 3,831 View
  • 159 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Optimal management of primary aldosteronism (PA) is crucial due to the increased risk of cardiovascular and cerebrovascular diseases. Adrenal venous sampling (AVS) is the gold standard method for determining subtype but is technically challenging and invasive. Some PA patients do not benefit clinically from surgery. We sought to develop an algorithm to improve decision- making before engaging in AVS and surgery in clinical practice.
Methods
We conducted the ongoing Korean Primary Aldosteronism Study at two tertiary centers. Study A involved PA patients with successful catheterization and a unilateral nodule on computed tomography and aimed to predict unilateral aldosterone-producing adenoma (n=367). Study B involved similar patients who underwent adrenalectomy and aimed to predict postoperative outcome (n=330). In study A, we implemented important feature selection using the least absolute shrinkage and selection operator regression.
Results
We developed a unilateral PA prediction model using logistic regression analysis: lowest serum potassium level ≤3.4 mEq/L, aldosterone-to-renin ratio ≥150, plasma aldosterone concentration ≥30 ng/mL, and body mass index <25 kg/m2 (area under the curve, 0.819; 95% confidence interval, 0.774 to 0.865; sensitivity, 97.6%; specificity, 25.5%). In study B, we identified female, hypertension duration <5 years, anti-hypertension medication <2.5 daily defined dose, and the absence of coronary artery disease as predictors of clinical success, using stepwise logistic regression models (sensitivity, 94.2%; specificity, 49.3%). We validated our algorithm in the independent validation dataset (n=53).
Conclusion
We propose this new outcome-driven diagnostic algorithm, simultaneously considering unilateral aldosterone excess and clinical surgical benefits in PA patients.

Citations

Citations to this article as recorded by  
  • Subtype-specific Body Composition and Metabolic Risk in Patients With Primary Aldosteronism
    Seung Shin Park, Chang Ho Ahn, Sang Wan Kim, Ji Won Yoon, Jung Hee Kim
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e788.     CrossRef
  • Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: A systematic review and meta‐analysis
    Luigi Marzano, Amir Kazory, Faeq Husain‐Syed, Claudio Ronco
    Clinical Endocrinology.2023; 99(1): 17.     CrossRef
  • 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism
    Jeonghoon Ha, Jung Hwan Park, Kyoung Jin Kim, Jung Hee Kim, Kyong Yeun Jung, Jeongmin Lee, Jong Han Choi, Seung Hun Lee, Namki Hong, Jung Soo Lim, Byung Kwan Park, Jung-Han Kim, Kyeong Cheon Jung, Jooyoung Cho, Mi-kyung Kim, Choon Hee Chung
    Endocrinology and Metabolism.2023; 38(6): 597.     CrossRef
  • Correlation of Histopathologic Subtypes of Primary Aldosteronism with Clinical Phenotypes and Postsurgical Outcomes
    Chang Ho Ahn, You-Bin Lee, Jae Hyeon Kim, Young Lyun Oh, Jung Hee Kim, Kyeong Cheon Jung
    The Journal of Clinical Endocrinology & Metabolism.2023;[Epub]     CrossRef
Close layer
Calcium & Bone Metabolism
Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis
Sung Hye Kong, Han Na Jang, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
Endocrinol Metab. 2022;37(2):344-358.   Published online April 25, 2022
DOI: https://doi.org/10.3803/EnM.2021.1374
  • 6,014 View
  • 279 Download
  • 16 Web of Science
  • 19 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Although recent studies comparing various dosages and intervals of vitamin D supplementation have been published, it is yet to be elucidated whether there is an appropriate dose or interval to provide benefit regarding fracture risk. We aimed to assess the published evidence available to date regarding the putative beneficial effects of vitamin D supplements on fractures and falls according to various dosages and intervals.
Methods
We performed a meta-analysis of randomized controlled studies reporting associations between vitamin D supplementation and the risks of fractures and falls in PubMed, EMBASE, and Cochrane library. Studies with supplements of ergocalciferol or calcitriol, those with a number of event ≤10, or those with a follow-up duration of less than 6 months were also excluded.
Results
Thirty-two studies were included in the final analysis. Vitamin D supplementation with daily dose of 800 to 1,000 mg was associated with lower risks of osteoporotic fracture and fall (pooled relative risk [RR], 0.87; 95% confidence interval [CI], 0.78 to 0.97 and RR, 0.91; 95% CI, 0.85 to 0.98), while studies with <800 or >1,000 mg/day did not. Also, among intervals, daily administration of vitamin D was associated with the reduced risk of falls, while intermittent dose was not. Also, patients with vitamin D deficiency showed a significant risk reduction of falls after vitamin D supplementation.
Conclusion
Daily vitamin D dose of 800 to 1,000 IU was the most probable way to reduce the fracture and fall risk. Further studies designed with various regimens and targeted vitamin D levels are required to elucidate the benefits of vitamin D supplements.

Citations

Citations to this article as recorded by  
  • Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults
    Nataliia Grygorieva, Mykola Tronko, Volodymir Kovalenko, Serhiy Komisarenko, Tetiana Tatarchuk, Ninel Dedukh, Mykola Veliky, Serhiy Strafun, Yulia Komisarenko, Andrii Kalashnikov, Valeria Orlenko, Volodymyr Pankiv, Oleg Shvets, Inna Gogunska, Svitlana Reg
    Nutrients.2024; 16(2): 270.     CrossRef
  • Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population
    Pawel Pludowski, William B. Grant, Spyridon N. Karras, Armin Zittermann, Stefan Pilz
    Nutrients.2024; 16(3): 391.     CrossRef
  • Clinical Characteristics and Outcomes of Limb Fractures in Saudi Children
    Lamia Aldhbiban, Fai Alhoshan, Raghad Alomari, Shahad A Almatrafi, Yousef Alanazi, Samir Alsayegh, Haifa Y Alfaraidi, Ayman H Jawadi, Fahad N Aljuraibah
    Cureus.2024;[Epub]     CrossRef
  • The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches
    Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
    Clinical Rheumatology.2024; 43(5): 1421.     CrossRef
  • The multi-faceted nature of age-associated osteoporosis
    A.E. Smit, O.C. Meijer, E.M. Winter
    Bone Reports.2024; 20: 101750.     CrossRef
  • Vitamin D Deficiency in Patients With Low-Energy Hip Fractures in Accordance With the Mediterranean Paradox
    Christos Konstantinidis, Ourania Psoma, Christos Kotsias, Vasileios Panagiotopoulos , Sotiris Plakoutsis, Dimitrios Tsiampas, Dimitrios Vardakas, Dimitrios Giotis
    Cureus.2024;[Epub]     CrossRef
  • Association of vitamin and/or nutritional supplements with fall among patients with diabetes: A prospective study based on ACCORD and UK Biobank
    Lingfang He, Tianqi Ma, Guogang Zhang, Xunjie Cheng, Yongping Bai
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
    Gavriela Voulgaridou, Sousana K. Papadopoulou, Paraskevi Detopoulou, Despoina Tsoumana, Constantinos Giaginis, Foivi S. Kondyli, Evgenia Lymperaki, Agathi Pritsa
    Diseases.2023; 11(1): 29.     CrossRef
  • Recent advances in the identification of related factors and preventive strategies of hip fracture
    Yaohui Yu, Yudan Wang, Xiaoli Hou, Faming Tian
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society?
    Sadao Yoshida, Ryo Shiraishi, Yuki Nakayama, Yasuko Taira
    Nutrients.2023; 15(13): 2991.     CrossRef
  • Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements
    Valentina Maggini, Giada Crescioli, Ilaria Ippoliti, Eugenia Gallo, Francesca Menniti-Ippolito, Adelaide Chiaravalloti, Vittorio Mascherini, Roberto Da Cas, Simona Potenza, Giulia Gritti, Maria Galiulo, Laura Sottosanti, Alfredo Vannacci, Niccolò Lombardi
    Journal of Clinical Medicine.2023; 12(14): 4726.     CrossRef
  • Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly
    Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, Antonio Bianchi, Antonella Giampietro, Margherita Medici, Agnese Allora, Luigi di Filippo, Maria Rosaria Ambrosio, Alfredo Pontecorvi, Maria Chiara Zatelli, Laura De Marinis, Andrea Giustina
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e58.     CrossRef
  • Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases
    E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer
    Journal of Clinical Densitometry.2023; 26(4): 101432.     CrossRef
  • Diagnosis, prevention and treatment of vitamin D deficiency in adults: Ukrainian experts consensus statement
    N.V. Grygorieva, M.D. Tronko, V.M. Kovalenko, S.V. Komisarenko, T.F. Tatarchuk, N.V. Dedukh, M.M. Veliky, S.S. Strafun, Y.I. Komisarenko, A.V. Kalashnikov, V.L. Orlenko, V.I. Pankiv, O.V. Shvets, I.V. Gogunska, S.I. Regeda
    PAIN, JOINTS, SPINE.2023; 13(2): 60.     CrossRef
  • Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients
    Menglin Pang, Lin Chen, Na Jiang, Mengmeng Jiang, Baofeng Wang, Lili Wang, Xiao-yan Jia
    Kidney and Blood Pressure Research.2023; 48(1): 231.     CrossRef
  • Vitamin D for Clinical Diseases in Women: An Indispensable Factor in Medicine and Dentistry
    Dario Calafiore, Leonzio Fortunato, Mario Migliario
    Journal of Clinical Medicine.2022; 11(11): 3104.     CrossRef
  • Malnutrition in Older Adults—Effect on Falls and Fractures: A Narrative Review
    Malgorzata Kupisz-Urbanska, Ewa Marcinowska-Suchowierska
    Nutrients.2022; 14(15): 3123.     CrossRef
  • Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
    Thierry Chevalley, Maria Luisa Brandi, Kevin D. Cashman, Etienne Cavalier, Nicholas C. Harvey, Stefania Maggi, Cyrus Cooper, Nasser Al-Daghri, Oliver Bock, Olivier Bruyère, Mario Miguel Rosa, Bernard Cortet, Alfonso J. Cruz-Jentoft, Antonio Cherubini, Bes
    Aging Clinical and Experimental Research.2022; 34(11): 2603.     CrossRef
  • The Relationship of Osteoporosis with Menopause: Review of Article
    Hadeel Anwar Alsarraje, *Liqaa Khalel Alhyali
    International Journal of Research in Medical Sciences and Technology.2022; 14(01): 127.     CrossRef
Close layer
Miscellaneous
Corrigendum: Correction of Acknowledgments. Transformation of Mature Osteoblasts into Bone Lining Cells and RNA Sequencing-Based Transcriptome Profiling of Mouse Bone during Mechanical Unloading
A Ram Hong, Kwangsoo Kim, Ji Yeon Lee, Jae-Yeon Yang, Jung Hee Kim, Chan Soo Shin, Sang Wan Kim
Endocrinol Metab. 2021;36(6):1314.   Published online November 18, 2021
DOI: https://doi.org/10.3803/EnM.2021.601
Corrects: Endocrinol Metab 2020;35(2):456
  • 3,918 View
  • 83 Download
PDFPubReader   ePub   
Close layer
Adrenal Gland
Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea
Eu Jeong Ku, Chaelin Lee, Jaeyoon Shim, Sihoon Lee, Kyoung-Ah Kim, Sang Wan Kim, Yumie Rhee, Hyo-Jeong Kim, Jung Soo Lim, Choon Hee Chung, Sung Wan Chun, Soon-Jib Yoo, Ohk-Hyun Ryu, Ho Chan Cho, A Ram Hong, Chang Ho Ahn, Jung Hee Kim, Man Ho Choi
Endocrinol Metab. 2021;36(5):1131-1141.   Published online October 21, 2021
DOI: https://doi.org/10.3803/EnM.2021.1149
  • 5,178 View
  • 211 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Conventional diagnostic approaches for adrenal tumors require multi-step processes, including imaging studies and dynamic hormone tests. Therefore, this study aimed to discriminate adrenal tumors from a single blood sample based on the combination of liquid chromatography-mass spectrometry (LC-MS) and machine learning algorithms in serum profiling of adrenal steroids.
Methods
The LC-MS-based steroid profiling was applied to serum samples obtained from patients with nonfunctioning adenoma (NFA, n=73), Cushing’s syndrome (CS, n=30), and primary aldosteronism (PA, n=40) in a prospective multicenter study of adrenal disease. The decision tree (DT), random forest (RF), and extreme gradient boost (XGBoost) were performed to categorize the subtypes of adrenal tumors.
Results
The CS group showed higher serum levels of 11-deoxycortisol than the NFA group, and increased levels of tetrahydrocortisone (THE), 20α-dihydrocortisol, and 6β-hydroxycortisol were found in the PA group. However, the CS group showed lower levels of dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEA-S) than both the NFA and PA groups. Patients with PA expressed higher serum 18-hydroxycortisol and DHEA but lower THE than NFA patients. The balanced accuracies of DT, RF, and XGBoost for classifying each type were 78%, 96%, and 97%, respectively. In receiver operating characteristics (ROC) analysis for CS, XGBoost, and RF showed a significantly greater diagnostic power than the DT. However, in ROC analysis for PA, only RF exhibited better diagnostic performance than DT.
Conclusion
The combination of LC-MS-based steroid profiling with machine learning algorithms could be a promising one-step diagnostic approach for the classification of adrenal tumor subtypes.

Citations

Citations to this article as recorded by  
  • Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
    Nathan Mullen, James Curneen, Padraig T Donlon, Punit Prakash, Irina Bancos, Mark Gurnell, Michael C Dennedy
    Endocrine Reviews.2024; 45(1): 125.     CrossRef
  • Steroid profiling in adrenal disease
    Danni Mu, Dandan Sun, Xia Qian, Xiaoli Ma, Ling Qiu, Xinqi Cheng, Songlin Yu
    Clinica Chimica Acta.2024; 553: 117749.     CrossRef
  • Plasma steroid profiling combined with machine learning for the differential diagnosis in mild autonomous cortisol secretion from nonfunctioning adenoma in patients with adrenal incidentalomas
    Danni Mu, Xia Qian, Yichen Ma, Xi Wang, Yumeng Gao, Xiaoli Ma, Shaowei Xie, Lian Hou, Qi Zhang, Fang Zhao, Liangyu Xia, Liling Lin, Ling Qiu, Jie Wu, Songlin Yu, Xinqi Cheng
    Endocrine Practice.2024;[Epub]     CrossRef
  • Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches
    Alessandro Prete, Irina Bancos
    Nature Reviews Endocrinology.2024;[Epub]     CrossRef
  • Serum and hair steroid profiles in patients with nonfunctioning pituitary adenoma undergoing surgery: A prospective observational study
    Seung Shin Park, Yong Hwy Kim, Ho Kang, Chang Ho Ahn, Dong Jun Byun, Man Ho Choi, Jung Hee Kim
    The Journal of Steroid Biochemistry and Molecular Biology.2023; 230: 106276.     CrossRef
  • Recent Updates on the Management of Adrenal Incidentalomas
    Seung Shin Park, Jung Hee Kim
    Endocrinology and Metabolism.2023; 38(4): 373.     CrossRef
  • LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines
    Jongsung Noh, Chaelin Lee, Jung Hee Kim, Seung Woon Myung, Man Ho Choi
    Journal of Lipid Research.2023; 64(11): 100453.     CrossRef
  • 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism
    Jeonghoon Ha, Jung Hwan Park, Kyoung Jin Kim, Jung Hee Kim, Kyong Yeun Jung, Jeongmin Lee, Jong Han Choi, Seung Hun Lee, Namki Hong, Jung Soo Lim, Byung Kwan Park, Jung-Han Kim, Kyeong Cheon Jung, Jooyoung Cho, Mi-kyung Kim, Choon Hee Chung
    Endocrinology and Metabolism.2023; 38(6): 597.     CrossRef
  • Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
    Aliya Lakhani, Da Hyun Kang, Yea Eun Kang, Junyoung O. Park
    Endocrinology and Metabolism.2023; 38(6): 619.     CrossRef
  • Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population
    Ying Jing, Jinbo Hu, Rong Luo, Yun Mao, Zhixiao Luo, Mingjun Zhang, Jun Yang, Ying Song, Zhengping Feng, Zhihong Wang, Qingfeng Cheng, Linqiang Ma, Yi Yang, Li Zhong, Zhipeng Du, Yue Wang, Ting Luo, Wenwen He, Yue Sun, Fajin Lv, Qifu Li, Shumin Yang
    Annals of Internal Medicine.2022; 175(10): 1383.     CrossRef
Close layer
Adrenal Gland
Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary Aldosteronism
Ye Seul Yang, Seung Hun Lee, Jung Hee Kim, Jee Hee Yoo, Jung Hyun Lee, Seo Young Lee, A Ram Hong, Dong-Hwa Lee, Jung-Min Koh, Jae Hyeon Kim, Sang Wan Kim
Endocrinol Metab. 2021;36(4):875-884.   Published online August 11, 2021
DOI: https://doi.org/10.3803/EnM.2021.1047
  • 5,093 View
  • 150 Download
  • 7 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Adrenal venous sampling (AVS) is performed to distinguish the subtype of primary aldosteronism (PA). The clinical implication of contralateral suppression (CS; aldosterone/cortisolnondominantperipheral) at AVS remains unclear. We aimed to investigate the clinical significance of CS and its impact on postoperative outcomes after unilateral adrenalectomy.
Methods
In this retrospective observational multi-center study, we analyzed PA patients who underwent both successful adrenocorticotropin hormone-stimulated AVS and unilateral adrenalectomy. Successful cannulation was defined as the selectivity index (cortisoladrenal/ cortisolperipheral) ≥3. Clinical and biochemical outcomes after unilateral adrenalectomy were evaluated based on the international Primary Aldosteronism Surgical Outcome consensus.
Results
Among 263 patients analyzed, 247 had CS (93.9%). Patients with CS had lower serum potassium levels, higher plasma aldosterone concentration, higher aldosterone-to-renin ratio (ARR), and larger adenoma size than those without CS. Those with CS showed significantly higher lateralization index than those without CS (P<0.001). Although postoperative blood pressure and ARR significantly decreased in those with CS, clinical and biochemical outcomes were comparable in both groups. When the cut-off value of age was determined using receiver operating characteristic (ROC) analysis, patients aged ≥50 years old with contralateral suppression index (CSI; the ratio between aldosterone/cortisolnondominant and aldosterone/cortisolperipheral) ≤0.26 had greater odds ratio (6.43; 95% confidence interval, 1.30 to 31.69) of incident chronic kidney disease than those aged <50 years with CSI >0.26 after adjusting for other factors.
Conclusion
CS may not predict postoperative clinical and biochemical outcomes in subjects with unilateral aldosterone excess, but it is associated with postsurgical deterioration of renal function in subjects over 50 years with CSI ≤0.26.

Citations

Citations to this article as recorded by  
  • Treatment decision based on unilateral index from nonadrenocorticotropic hormone-stimulated and adrenocorticotropic hormone-stimulated adrenal vein sampling in primary aldosteronism
    Xizi Zhang, Xiaoyu Shu, Feifei Wu, Jun Yang, Qingfeng Cheng, Zhipeng Du, Ying Song, Yi Yang, Jinbo Hu, Yue Wang, Qifu Li, Shumin Yang
    Journal of Hypertension.2024; 42(3): 450.     CrossRef
  • Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism
    Nathalie Voss, Sara Mørup, Caroline Clausen, Claus larsen Feltoft, Jan Viberg Jepsen, Mads Hornum, Mikkel Andreassen, Jesper Krogh
    Clinical Endocrinology.2023; 98(3): 306.     CrossRef
  • Factors Predicting Long-term Estimated Glomerular Filtration Rate Decrease, a Reliable Indicator of Renal Function After Adrenalectomy in Primary Aldosteronism
    Qiyu He, Zhimin Tan, Yu Liu, Liang Zhou
    Endocrine Practice.2023; 29(3): 199.     CrossRef
  • Correlation of Histopathologic Subtypes of Primary Aldosteronism with Clinical Phenotypes and Postsurgical Outcomes
    Chang Ho Ahn, You-Bin Lee, Jae Hyeon Kim, Young Lyun Oh, Jung Hee Kim, Kyeong Cheon Jung
    The Journal of Clinical Endocrinology & Metabolism.2023;[Epub]     CrossRef
  • Prognostic value of contralateral suppression for remission after surgery in patients with primary aldosteronism
    Sara Mørup, Nathalie Voss, Caroline Clausen, Claus Larsen Feltoft, Mikkel Andreassen, Jesper Krogh
    Clinical Endocrinology.2022; 96(6): 793.     CrossRef
  • Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary Aldosteronism (Endocrinol Metab 2021;36:875-84, Ye Seul Yang et al.)
    Zhimin Tan, Qiyu He, Liang Zhou
    Endocrinology and Metabolism.2022; 37(6): 951.     CrossRef
  • Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary Aldosteronism (Endocrinol Metab 2021;36:875-84, Ye Seul Yang et al.)
    Ye Seul Yang, Sang Wan Kim
    Endocrinology and Metabolism.2022; 37(6): 953.     CrossRef
Close layer
Adrenal Gland
Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age (Endocrinol Metab 2021;36:401-12, Seung Hun Lee et al.)
Seung Hun Lee, Jong Woo Kim, Hyun-Ki Yoon, Jung-Min Koh, Chan Soo Shin, Sang Wan Kim, Jung Hee Kim
Endocrinol Metab. 2021;36(4):914-915.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.402
[Original]
  • 2,972 View
  • 80 Download
  • 2 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • Strategies for subtyping primary aldosteronism
    Yun-Hsuan Yang, Yu-Ling Chang, Bo-Ching Lee, Ching-Chu Lu, Wei-Ting Wang, Ya-Hui Hu, Han-Wen Liu, Yung-Hsiang Lin, Chin-Chen Chang, Wan-Chen Wu, Fen-Yu Tseng, Yen-Hung Lin, Vin-Cent Wu, Chii-Min Hwu
    Journal of the Formosan Medical Association.2024; 123: S114.     CrossRef
  • Diagnostic consistency between computed tomography and adrenal vein sampling of primary aldosteronism: leading to successful curative outcome after adrenalectomy; a retrospective study
    Byung-Chang Kim, Hyun-Ki Yoon, Kye Jin Park, Gun Ha Kim, Shin Jeong Pak, Douk Kwon, Jae Won Cho, Won Woong Kim, Yu-Mi Lee, Jung-Min Koh, Seung Hun Lee, Ki-Wook Chung, Tae-Yon Sung
    International Journal of Surgery.2024; 110(2): 839.     CrossRef
Close layer
Clinical Study
Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age
Seung Hun Lee, Jong Woo Kim, Hyun-Ki Yoon, Jung-Min Koh, Chan Soo Shin, Sang Wan Kim, Jung Hee Kim
Endocrinol Metab. 2021;36(2):401-412.   Published online March 31, 2021
DOI: https://doi.org/10.3803/EnM.2020.901
  • 4,879 View
  • 158 Download
  • 17 Web of Science
  • 16 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Guidelines by the Endocrine Society Guideline on bypassing adrenal vein sampling (AVS) in patients <35 years old with marked primary aldosteronism (PA) (hypokalemia and elevated plasma aldosterone concentration [PAC]) and a unilateral lesion on computed tomography (CT) are based on limited number of studies. We aimed to determine the accuracy of CT in PA patients according to age.
Methods
In this retrospective study, we investigated the concordance between CT and AVS in 466 PA patients from two tertiary centers who successfully underwent AVS.
Results
CT had an overall accuracy of 64.4% (300/466). In the group with unilateral lesion, patients with hypokalemia had higher concordance than those without hypokalemia (85.0% vs. 43.6%, P<0.001). In the group with marked PA (hypokalemia and PAC >15.9 ng/dL) and unilateral lesion, accuracy of CT was 84.6% (11/13) in patients aged <35 years; 100.0% (20/20), aged 35 to 39 years; 89.4% (59/66), aged 40 to 49 years; and 79.8% (79/99), aged ≥50 years. Cut-off age and PAC for concordance was <50 years and >29.6 ng/dL, respectively. The significant difference in accuracy of CT in 198 patients with marked PA and a unilateral lesion between the <50-year age group and ≥50-year age group (90.9% vs. 79.8%, P=0.044) disappeared in 139 of 198 patients with PAC > 30.0 ng/dL (91.9% vs. 87.7%, P=0.590).
Conclusion
Patients with hypokalemia, PAC >30.0 ng/dL, and unilateral lesion were at high risk of unilateral PA regardless of age.

Citations

Citations to this article as recorded by  
  • Predicting Bilateral Subtypes of Primary Aldosteronism Without Adrenal Vein Sampling: A Systematic Review and Meta-analysis
    Elisabeth Ng, Stella May Gwini, Winston Zheng, Peter J Fuller, Jun Yang
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e837.     CrossRef
  • Subtype-specific Body Composition and Metabolic Risk in Patients With Primary Aldosteronism
    Seung Shin Park, Chang Ho Ahn, Sang Wan Kim, Ji Won Yoon, Jung Hee Kim
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e788.     CrossRef
  • Imaging Concordance With Vein Sampling for Primary Aldosteronism: A Cohort Study and Literature Review
    Sara Cartwright, MaKayla Gordon, Jessica Shank, Abbey Fingeret
    Journal of Surgical Research.2024; 296: 1.     CrossRef
  • Best Practices: Indications and Procedural Controversies of Adrenal Vein Sampling for Primary Aldosteronism
    Keith B. Quencer, Abhilasha Singh, Anu Sharma
    American Journal of Roentgenology.2023; 220(2): 190.     CrossRef
  • Accuracy of Gallium-68 Pentixafor Positron Emission Tomography–Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism
    Jinbo Hu, Tingting Xu, Hang Shen, Ying Song, Jun Yang, Aipin Zhang, Haoyuan Ding, Naiguo Xing, Zhuoyuan Li, Lin Qiu, Linqiang Ma, Yi Yang, Zhengping Feng, Zhipeng Du, Wenwen He, Yue Sun, Jun Cai, Qifu Li, Yue Chen, Shumin Yang, Mei Mei, Suxin Luo, Kangla
    JAMA Network Open.2023; 6(2): e2255609.     CrossRef
  • Adrenal Vein Sampling in the Young – Necessary or Not?
    Eleftheria Gkaniatsa, Oskar Ragnarsson
    Experimental and Clinical Endocrinology & Diabetes.2023; 131(07/08): 435.     CrossRef
  • 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism
    Jeonghoon Ha, Jung Hwan Park, Kyoung Jin Kim, Jung Hee Kim, Kyong Yeun Jung, Jeongmin Lee, Jong Han Choi, Seung Hun Lee, Namki Hong, Jung Soo Lim, Byung Kwan Park, Jung-Han Kim, Kyeong Cheon Jung, Jooyoung Cho, Mi-kyung Kim, Choon Hee Chung
    Endocrinology and Metabolism.2023; 38(6): 597.     CrossRef
  • Correlation of Histopathologic Subtypes of Primary Aldosteronism with Clinical Phenotypes and Postsurgical Outcomes
    Chang Ho Ahn, You-Bin Lee, Jae Hyeon Kim, Young Lyun Oh, Jung Hee Kim, Kyeong Cheon Jung
    The Journal of Clinical Endocrinology & Metabolism.2023;[Epub]     CrossRef
  • Indices of ACTH‐stimulated adrenal venous sampling as predictors of postsurgical outcomes in primary aldosteronism
    Seung Hun Lee, Jong Woo Kim, Hyun‐Ki Yoon, Sang Wan Kim, Su Jin Kim, Kyu Eun Lee, Yu‐Mi Lee, Tae‐Yon Sung, Suck Joon Hong, Chan Soo Shin, Jung‐Min Koh, Jung Hee Kim
    Clinical Endocrinology.2022; 96(4): 521.     CrossRef
  • Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism
    Chang Ho Ahn, Hee Young Na, So Yeon Park, Hyeong Won Yu, Su‐Jin Kim, June Young Choi, Kyu Eun Lee, Sang Wan Kim, Kyeong Cheon Jung, Jung Hee Kim
    Clinical Endocrinology.2022; 96(1): 30.     CrossRef
  • Letter to the Editor From Singhania et al: “Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades—Yet an Underdiagnosed Disorder”
    Pankaj Singhania, Rana Bhattacharjee
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(3): e1315.     CrossRef
  • Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism
    Ying Song, Jun Yang, Hang Shen, Elisabeth Ng, Peter J. Fuller, Zhengping Feng, Jinbo Hu, Linqiang Ma, Yi Yang, Zhipeng Du, Yue Wang, Ting Luo, Wenwen He, Qifu Li, Fei-Fei Wu, Shumin Yang
    Journal of Hypertension.2022; 40(9): 1692.     CrossRef
  • Validation of Existing Clinical Prediction Tools for Primary Aldosteronism Subtyping
    Barbora Kološová, Petr Waldauf, Dan Wichterle, Jan Kvasnička, Tomáš Zelinka, Ondřej Petrák, Zuzana Krátká, Lubomíra Forejtová, Jan Kaván, Jiří Widimský, Robert Holaj
    Diagnostics.2022; 12(11): 2806.     CrossRef
  • Fully automatic volume measurement of the adrenal gland on CT using deep learning to classify adrenal hyperplasia
    Taek Min Kim, Seung Jae Choi, Ji Yeon Ko, Sungwan Kim, Chang Wook Jeong, Jeong Yeon Cho, Sang Youn Kim, Young-Gon Kim
    European Radiology.2022; 33(6): 4292.     CrossRef
  • Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age (Endocrinol Metab 2021;36:401-12, Seung Hun Lee et al.)
    Seung Hun Lee, Jong Woo Kim, Hyun-Ki Yoon, Jung-Min Koh, Chan Soo Shin, Sang Wan Kim, Jung Hee Kim
    Endocrinology and Metabolism.2021; 36(4): 914.     CrossRef
  • Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age (Endocrinol Metab 2021;36:401-12, Seung Hun Lee et al.)
    Pankaj Singhania
    Endocrinology and Metabolism.2021; 36(4): 912.     CrossRef
Close layer
Clinical Study
Radioactive Parathyroid Adenomas on Sestamibi Scans: Low Parathyroid Hormone Secretory Potential and Large Volume
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
Endocrinol Metab. 2021;36(2):351-358.   Published online April 6, 2021
DOI: https://doi.org/10.3803/EnM.2020.823
  • 3,380 View
  • 124 Download
  • 2 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
We investigated the clinical characteristics of parathyroid adenomas according to radioactivity on 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) in primary hyperparathyroidism (PHPT) patients.
Methods
The study included 217 patients diagnosed with PHPT from 2000 to 2019 at Seoul National University Hospital who underwent 99mTc-MIBI SPECT/CT scans. On SPECT/CT, the radioactivity of parathyroid adenomas was measured as the ratio of the mean radioactivity count of the parathyroid adenoma to that of the contralateral thyroid.
Results
Tumors were localized by MIBI scans in 190 patients (MIBI [+] group) and by ultrasound or parathyroid four-dimensional CT in 27 patients (MIBI [–] group). The mean age was 55 years, and mean body mass index was 23.4 kg/m2. Patients in the MIBI (+) group had higher parathyroid hormone (iPTH) and lower 25-hydroxy vitamin D levels than those in the MIBI (–) group (168.0 pg/mL [interquartile range, IQR, 111.0 to 250.7] vs. 134.7 pg/mL [IQR, 98.2 to 191.2], P=0.049; 15.4 ng/mL [IQR, 11.1 to 20.8] vs. 21.2 ng/mL [IQR, 13.9 to 24.8], P=0.012, respectively). Patients in the MIBI (+) group had larger tumor volumes, but lower iPTH/volume ratios than those in the MIBI (–) group (1,216.66 [IQR, 513.40 to 2,663.02], 499.82 mm3 [IQR, 167.77 to 1,229.80], P=0.002; 0.18 [IQR, 0.08 to 0.46], 0.40 pg/mL/mm3 [IQR, 0.16 to 1.29], P=0.016, respectively). Adenoma radioactivity was positively correlated with calcium, iPTH, and volume (r=0.180, P=0.020; r=0.208, P=0.006; r=0.288, P<0.001, respectively), but not with iPTH/volume.
Conclusion
Parathyroid adenomas with positive MIBI scans had larger volumes and higher iPTH than adenomas with negative scans, but lower iPTH per unit volume.

Citations

Citations to this article as recorded by  
  • Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality
    Sung Hye Kong, Jeong Mo Bae, Jung Hee Kim, Sang Wan Kim, Dohyun Han, Chan Soo Shin
    Endocrinology and Metabolism.2024; 39(2): 375.     CrossRef
  • Atypical parathyroid tumor: clinical and parathyroid hormone response to surgical treatment
    Antonio Giulio Napolitano, Massimo Monacelli, Valeria Liparulo, Eleonora Coviello, Domenico Pourmolkara, Stefano Avenia, Andrea Polistena
    Annals of Surgical Treatment and Research.2023; 105(2): 76.     CrossRef
  • The Relationship between Planar and SPECT/CT Parameters and Functional Markers in Primary Hyperparathyroidism
    Guler Silov, Serpil Erdogan Ozbodur
    Diagnostics.2023; 13(20): 3182.     CrossRef
Close layer
Hypothalamus and Pituitary gland
Reference Ranges of Serum Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3: Results from a Multicenter Study in Healthy Korean Adults
In-Kyung Jeong, Jong Kyu Byun, Junghyun Noh, Sang Wan Kim, Yoon-Sok Chung, Tae Sun Park, Sung-Woon Kim
Endocrinol Metab. 2020;35(4):954-959.   Published online December 1, 2020
DOI: https://doi.org/10.3803/EnM.2020.785
  • 4,446 View
  • 125 Download
  • 2 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Insulin-like growth factor-I (IGF-I) plays a pivotal role in the diagnosis and treatment of growth hormone (GH) excess or deficiency. The GH study group of the Korean Endocrine Society aims to establish the Korean reference ranges of serum IGF-I and insulin-like growth factor binding protein-3 (IGFBP-3) and assess the relationship between IGF-I and IGFBP-3 and clinical parameters. Fasting serum was collected from healthy Korean adults at health promotion centers of five hospitals nationwide. Serum IGF-I and IGFBP-3 were measured via an immunoradiometric assay using a DSL kit (Diagnostic Systems Laboratories). Serum samples from 354 subjects (180 male, 174 female) were analyzed based on sex at 10-year intervals from 21 to 70 years. IGF-I levels were inversely correlated with age. After adjustment of age, the IGF-I/IGFBP-3 ratio was significantly negatively associated with blood pressure and free thyroxine and positively associated with weight, hemoglobin, creatinine, alanine transferase, fasting glucose, and thyroid stimulating hormone. Therefore, age- and sex-specific reference ranges of serum IGF-I and IGFBP-3 can be efficient in evaluating GH excess or deficiency in Korean population.

Citations

Citations to this article as recorded by  
  • Capillary blood as a complementary matrix for doping control purposes. Application to the definition of the individual longitudinal profile of IGF-1
    Carlotta Stacchini, Francesco Botrè, Xavier de la Torre, Monica Mazzarino
    Journal of Pharmaceutical and Biomedical Analysis.2023; 227: 115274.     CrossRef
Close layer
Clinical Study
Stimulated Salivary Cortisol as a Noninvasive Diagnostic Tool for Adrenal Insufficiency
Yoon Ji Kim, Jung Hee Kim, A Ram Hong, Kyeong Seon Park, Sang Wan Kim, Chan Soo Shin, Seong Yeon Kim
Endocrinol Metab. 2020;35(3):628-635.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.707
  • 5,870 View
  • 203 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Salivary cortisol is routinely used as a diagnostic test for Cushing syndrome. The diagnostic use of salivary cortisol for adrenal insufficiency (AI), however, is less established. We aimed to investigate the utility of morning basal and adrenocorticotropic hormone-stimulated salivary cortisol in diagnosing AI in Korean adults.
Methods
We prospectively included 120 subjects (female, n=70) from Seoul National University Hospital. AI was defined as a stimulated serum cortisol level of <496.8 nmol/L during the short Synacthen test (SST). Serum and saliva samples were drawn between 8:00 AM and 10:00 AM. Salivary cortisol levels were measured using an enzyme immunoassay kit.
Results
Thirty-four patients were diagnosed with AI according to the SST results. Age, sex, body mass index, serum albumin levels, and serum creatinine levels did not significantly differ between the normal and AI groups. Basal and stimulated salivary cortisol levels were positively correlated with basal (r=0.538) and stimulated serum cortisol levels (r=0.750), respectively (all P<0.001). Receiver operating characteristic curve analysis yielded a cutoff level of morning basal salivary cortisol of 3.2 nmol/L (sensitivity, 84.9%; specificity, 73.5%; area under the curve [AUC]=0.822). The optimal cutoff value of stimulated salivary cortisol was 13.2 nmol/L (sensitivity, 90.7%; specificity, 94.1%; AUC=0.959). Subjects with a stimulated salivary cortisol level above 13.2 nmol/L but a stimulated serum cortisol level below 496.8 nmol/L (n=2) had lower serum albumin levels than those showing a concordant response.
Conclusion
The diagnostic performance of stimulated salivary cortisol measurements after the SST was comparable to serum cortisol measurements for diagnosing AI.

Citations

Citations to this article as recorded by  
  • Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy
    Ulla Feldt-Rasmussen
    European Journal of Endocrinology.2024; 190(1): R10.     CrossRef
  • Turning Antibodies into Ratiometric Bioluminescent Sensors for Competition-Based Homogeneous Immunoassays
    Eva A. van Aalen, Joep J. J. Lurvink, Leandra Vermeulen, Benice van Gerven, Yan Ni, Remco Arts, Maarten Merkx
    ACS Sensors.2024; 9(3): 1401.     CrossRef
  • A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
    Suranut Charoensri, Richard J. Auchus
    Endocrinology and Metabolism.2024; 39(1): 73.     CrossRef
  • Diagnostic strategies in adrenal insufficiency
    Vasiliki Siampanopoulou, Elisavet Tasouli, Anna Angelousi
    Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(3): 141.     CrossRef
  • The association between neuropeptide oxytocin and neuropsychiatric disorders after orthopedic surgery stress in older patients
    Wanru Dong, Zengbo Ding, Xiao Wu, Ran Wan, Ying Liu, Liubao Pei, Weili Zhu
    BMC Geriatrics.2023;[Epub]     CrossRef
  • The Reliability of Salivary Cortisol Compared to Serum Cortisol for Diagnosing Adrenal Insufficiency with the Gold Standard ACTH Stimulation Test in Children
    Silvia Ciancia, Sjoerd A. A. van den Berg, Erica L. T. van den Akker
    Children.2023; 10(9): 1569.     CrossRef
  • РІВЕНЬ СТРЕСУ В ДІТЕЙ ШКІЛЬНОГО ВІКУ З COVID-19
    Г. А. Павлишин, О. І. Панченко
    Здобутки клінічної і експериментальної медицини.2023; (4): 119.     CrossRef
  • Secondary adrenal suppression related to high doses of inhaled corticosteroids in patients with severe asthma
    Mariana Lobato, João Gaspar-Marques, Pedro Carreiro-Martins, Paula Leiria-Pinto
    Annals of Allergy, Asthma & Immunology.2022; 128(4): 464.     CrossRef
  • Clinical and Technical Aspects in Free Cortisol Measurement
    Man Ho Choi
    Endocrinology and Metabolism.2022; 37(4): 599.     CrossRef
  • Continuous biomarker monitoring with single molecule resolution by measuring free particle motion
    Alissa D. Buskermolen, Yu-Ting Lin, Laura van Smeden, Rik B. van Haaften, Junhong Yan, Khulan Sergelen, Arthur M. de Jong, Menno W. J. Prins
    Nature Communications.2022;[Epub]     CrossRef
  • Reversible Immunosensor for the Continuous Monitoring of Cortisol in Blood Plasma Sampled with Microdialysis
    Laura van Smeden, Annet Saris, Khulan Sergelen, Arthur M. de Jong, Junhong Yan, Menno W. J. Prins
    ACS Sensors.2022; 7(10): 3041.     CrossRef
  • Adrenal insufficiency in HIV/AIDS: a review
    Simon Mifsud, Zachary Gauci, Mark Gruppetta, Charles Mallia Azzopardi, Stephen Fava
    Expert Review of Endocrinology & Metabolism.2021; 16(6): 351.     CrossRef
Close layer
Endocrine Research
Transformation of Mature Osteoblasts into Bone Lining Cells and RNA Sequencing-Based Transcriptome Profiling of Mouse Bone during Mechanical Unloading
A Ram Hong, Kwangsoo Kim, Ji Yeon Lee, Jae-Yeon Yang, Jung Hee Kim, Chan Soo Shin, Sang Wan Kim
Endocrinol Metab. 2020;35(2):456-469.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.456
Correction in: Endocrinol Metab 2021;36(6):1314
  • 7,652 View
  • 172 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We investigated RNA sequencing-based transcriptome profiling and the transformation of mature osteoblasts into bone lining cells (BLCs) through a lineage tracing study to better understand the effect of mechanical unloading on bone loss.
Methods
Dmp1-CreERt2(+):Rosa26R mice were injected with 1 mg of 4-hydroxy-tamoxifen three times a week starting at postnatal week 7, and subjected to a combination of botulinum toxin injection with left hindlimb tenotomy starting at postnatal week 8 to 10. The animals were euthanized at postnatal weeks 8, 9, 10, and 12. We quantified the number and thickness of X-gal(+) cells on the periosteum of the right and left femoral bones at each time point.
Results
Two weeks after unloading, a significant decrease in the number and a subtle change in the thickness of X-gal(+) cells were observed in the left hindlimbs compared with the right hindlimbs. At 4 weeks after unloading, the decrease in the thickness was accelerated in the left hindlimbs, although the number of labeled cells was comparable. RNA sequencing analysis showed downregulation of 315 genes in the left hindlimbs at 2 and 4 weeks after unloading. Of these, Xirp2, AMPD1, Mettl11b, NEXN, CYP2E1, Bche, Ppp1r3c, Tceal7, and Gadl1 were upregulated during osteoblastogenic/osteocytic and myogenic differentiation in vitro.
Conclusion
These findings demonstrate that mechanical unloading can accelerate the transformation of mature osteoblasts into BLCs in the early stages of bone loss in vivo. Furthermore, some of the genes involved in this process may have a pleiotropic effect on both bone and muscle.

Citations

Citations to this article as recorded by  
  • Insights and implications of sexual dimorphism in osteoporosis
    Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C. Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
    Bone Research.2024;[Epub]     CrossRef
  • METTLing in Stem Cell and Cancer Biology
    John G. Tooley, James P. Catlin, Christine E. Schaner Tooley
    Stem Cell Reviews and Reports.2023; 19(1): 76.     CrossRef
  • Three's a crowd – why did three N-terminal methyltransferases evolve for one job?
    Meghan M. Conner, Christine E. Schaner Tooley
    Journal of Cell Science.2023;[Epub]     CrossRef
  • Unlocking the mysteries of alpha-N-terminal methylation and its diverse regulatory functions
    Panyue Chen, Rong Huang, Tony R. Hazbun
    Journal of Biological Chemistry.2023; 299(7): 104843.     CrossRef
  • Examining Mechanisms for Voltage-Sensitive Calcium Channel-Mediated Secretion Events in Bone Cells
    Perla C. Reyes Fernandez, Christian S. Wright, Mary C. Farach-Carson, William R. Thompson
    Calcified Tissue International.2023; 113(1): 126.     CrossRef
  • Reactivation of Bone Lining Cells are Attenuated Over Repeated Anti-sclerostin Antibody Administration
    A Ram Hong, Jae-Yeon Yang, Ji Yeon Lee, Joonho Suh, Yun-Sil Lee, Jung-Eun Kim, Sang Wan Kim
    Calcified Tissue International.2022; 111(5): 495.     CrossRef
  • Purine metabolism in the development of osteoporosis
    Keda Yang, Jie Li, Lin Tao
    Biomedicine & Pharmacotherapy.2022; 155: 113784.     CrossRef
  • Effects of Gabapentin and Pregabalin on Calcium Homeostasis: Implications for Physical Rehabilitation of Musculoskeletal Tissues
    Perla C. Reyes Fernandez, Christian S. Wright, Stuart J. Warden, Julia Hum, Mary C. Farach-Carson, William R. Thompson
    Current Osteoporosis Reports.2022; 20(6): 365.     CrossRef
  • Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta
    Pierre Moffatt, Iris Boraschi-Diaz, Juliana Marulanda, Ghalib Bardai, Frank Rauch
    International Journal of Molecular Sciences.2021; 22(10): 5290.     CrossRef
  • Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development
    James P. Catlin, Leandro N. Marziali, Benjamin Rein, Zhen Yan, M. Laura Feltri, Christine E. Schaner Tooley
    Cell Death & Disease.2021;[Epub]     CrossRef
Close layer
Bone Metabolism
Effects of Resistance Exercise on Bone Health
A Ram Hong, Sang Wan Kim
Endocrinol Metab. 2018;33(4):435-444.   Published online November 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.4.435
  • 22,715 View
  • 375 Download
  • 103 Web of Science
  • 107 Crossref
AbstractAbstract PDFPubReader   ePub   

The prevalence of chronic diseases including osteoporosis and sarcopenia increases as the population ages. Osteoporosis and sarcopenia are commonly associated with genetics, mechanical factors, and hormonal factors and primarily associated with aging. Many older populations, particularly those with frailty, are likely to have concurrent osteoporosis and sarcopenia, further increasing their risk of disease-related complications. Because bones and muscles are closely interconnected by anatomy, metabolic profile, and chemical components, a diagnosis should be considered for both sarcopenia and osteoporosis, which may be treated with optimal therapeutic interventions eliciting pleiotropic effects on both bones and muscles. Exercise training has been recommended as a promising therapeutic strategy to encounter the loss of bone and muscle mass due to osteosarcopenia. To stimulate the osteogenic effects for bone mass accretion, bone tissues must be exposed to mechanical load exceeding those experienced during daily living activities. Of the several exercise training programs, resistance exercise (RE) is known to be highly beneficial for the preservation of bone and muscle mass. This review summarizes the mechanisms of RE for the preservation of bone and muscle mass and supports the clinical evidences for the use of RE as a therapeutic option in osteosarcopenia.

Citations

Citations to this article as recorded by  
  • Effect of COVID‐19 pandemic on lifestyle and bone mineral density in young adults
    Darina Falbová, Viktória Kovalčíková, Radoslav Beňuš, Simona Sulis, Lenka Vorobeľová
    American Journal of Human Biology.2024;[Epub]     CrossRef
  • Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health
    Gregório Corrêa Guimarães, João Bosco Costa Coelho, João Gabriel Oliveira Silva, Ana Carolina Chalfun de Sant’Ana, Cássia Alves Carrilho de Sá, Júlia Marques Moreno, Lívia Marçal Reis, Camila Souza de Oliveira Guimarães
    Osteoporosis International.2024; 35(4): 575.     CrossRef
  • Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial
    Vaida Petrauskiene, Matthias Hellberg, Philippa Svensson, Yunan Zhou, Naomi Clyne
    Clinical Kidney Journal.2024;[Epub]     CrossRef
  • Atp6v1h Deficiency Blocks Bone Loss in Simulated Microgravity Mice through the Fos-Jun-Src-Integrin Pathway
    Zanyan Zhao, Xiangpu Wang, Yu Ma, Xiaohong Duan
    International Journal of Molecular Sciences.2024; 25(1): 637.     CrossRef
  • Exercise and Musculoskeletal Health in Men With Low Bone Mineral Density: A Systematic Review
    Katherine Hu, Maree Cassimatis, Christian Girgis
    Archives of Rehabilitation Research and Clinical Translation.2024; 6(1): 100313.     CrossRef
  • Influence of 8-weeks of supervised static stretching or resistance training of pectoral major muscles on maximal strength, muscle thickness and range of motion
    Tim Wohlann, Konstantin Warneke, Vincent Kalder, David G. Behm, Tobias Schmidt, Stephan Schiemann
    European Journal of Applied Physiology.2024;[Epub]     CrossRef
  • High-Protein Diets during either Resistance or Concurrent Training Have No Detrimental Effect on Bone Parameters in Resistance-Trained Males
    Reza Bagheri, Zohreh Karimi, Zeynabalsadat Mousavi, Mahdi Ziaee Bashirzad, Donny M. Camera, Ramin Sadeghi, Vahid Reza Dabbagh, Mehdi Kargarfard, Frederic Dutheil
    Nutrients.2024; 16(2): 325.     CrossRef
  • Cafeteria Diet Can Affect Bone Microarchitecture in Sedentary and Trained Male Rats
    Marcio Koiti Saito, Beatriz Kawano de Oliveira, Ana Paula Macedo, Caio Sorrentino dos Santos, Ricardo Tadeu Lopes, Jéssica Suzuki Yamanaka, Antonio Carlos Shimano
    Journal of Clinical Densitometry.2024; 27(2): 101467.     CrossRef
  • The Relationship Among Probable SARCopenia, Osteoporosis and SuprasPinatus Tendon Tears in Postmenopausal Women: The SARCOSP Study
    Murat Kara, Özgür Kara, Mahmut Esad Durmuş, Pelin Analay, Fatıma Edibe Şener, Beyza Nur Çıtır, Gizem Olgu Korkmaz, Zeliha Ünlü, Tülay Tiftik, Eda Gürçay, Cevriye Mülkoğlu, Berkay Yalçınkaya, Fatih Bağcıer, Mahmud Fazıl Aksakal, Kübra Erdoğan, Ahmet Sertçe
    Calcified Tissue International.2024; 114(4): 340.     CrossRef
  • Low Bone Mass in Ambulatory Spinal Muscular Atrophy: A Proactive Approach for an Often-Overlooked Impairment
    Caitlin Trancho, Bailey Stickney, Stacy Kinirons, David Uher, Cara H. Kanner, Ashwini K. Rao, Michael P. McDermott, Carol Ewing Garber, Darryl C. De Vivo, Jacqueline Montes
    Journal of Clinical Medicine.2024; 13(5): 1336.     CrossRef
  • Predictors of Hand Grip Strength in Adults Without Sarcopenia: Data From the NHANES, 2013–2014
    Mansour M Alotaibi
    Current Developments in Nutrition.2024; 8(5): 102149.     CrossRef
  • Why don't women engage in muscle strength exercise? An integrative review
    A. M. Stimson, C. Anderson, A.‐M. Holt, A. J. Henderson
    Health Promotion Journal of Australia.2024;[Epub]     CrossRef
  • Plant-Based Diets versus the Mediterranean Dietary Pattern and Their Socio-Demographic Determinants in the Spanish Population: Influence on Health and Lifestyle Habits
    Elena Sandri, Marco Sguanci, Eva Cantín Larumbe, Germán Cerdá Olmedo, Lisa Ursula Werner, Michela Piredda, Stefano Mancin
    Nutrients.2024; 16(9): 1278.     CrossRef
  • From Cells to Environment: Exploring the Interplay between Factors Shaping Bone Health and Disease
    Samradhi Singh, Devojit Kumar Sarma, Vinod Verma, Ravinder Nagpal, Manoj Kumar
    Medicina.2023; 59(9): 1546.     CrossRef
  • Effect of resistance exercise on bone health of old aged individuals: Review
    A. Khanna
    Science & Sports.2023; 38(4): 323.     CrossRef
  • Relationship between physical exercise and COVID-19 (SARS-CoV-2): systematic review
    Robson Chacon Castoldi, Juliana Cristina de Ângelo, Thiago Teixeira Pereira, Rodrigo Martins Dias, Fábio Juliano Negrão
    Sport Sciences for Health.2023; 19(1): 55.     CrossRef
  • Impact of Physical Rehabilitation on Bone Biomarkers in Non-Metastatic Breast Cancer Women: A Systematic Review and Meta-Analysis
    Alessandro de Sire, Lorenzo Lippi, Nicola Marotta, Arianna Folli, Dario Calafiore, Stefano Moalli, Alessio Turco, Antonio Ammendolia, Nicola Fusco, Marco Invernizzi
    International Journal of Molecular Sciences.2023; 24(2): 921.     CrossRef
  • Does wing use and disuse cause behavioural and musculoskeletal changes in domestic fowl ( Gallus gallus domesticus )?
    Renée C. Garant, Bret W. Tobalske, Neila Ben Sassi, Nienke van Staaveren, Dan Tulpan, Tina Widowski, Donald R. Powers, Alexandra Harlander-Matauschek
    Royal Society Open Science.2023;[Epub]     CrossRef
  • Increased fat mass negatively influences femoral neck bone mineral density in men but not women
    Nipith Charoenngam, Caroline M. Apovian, Chatlert Pongchaiyakul
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Influence of Strength Training Variables on Neuromuscular and Morphological Adaptations in Prepubertal Children: A Systematic Review
    Alberto Sánchez Pastor, Carlos García-Sánchez, Moisés Marquina Nieto, Alfonso de la Rubia
    International Journal of Environmental Research and Public Health.2023; 20(6): 4833.     CrossRef
  • The Role of Oxidative Stress in Multiple Exercise-Regulated Bone Homeostasis
    Haoyang Gao, Yilong Zhao, Linlin Zhao, Zhikun Wang, Kai Yan, Bo Gao, Lingli Zhang
    Aging and disease.2023; 14(5): 1555.     CrossRef
  • Kadınlarda Fiziksel Aktivite ve Egzersizin Osteoporozu Önleme ve Tedavi Edici Rolü
    Sümena HAREKET, İlknur NAZ GÜRŞAN
    Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.2023; 8(1): 73.     CrossRef
  • Osteosarcopenia as a satellite of aging
    B. I. Isaeva, K. M. Alieva-Kharkharova
    Meditsinskiy sovet = Medical Council.2023; 17(9): 130.     CrossRef
  • Examining Physical Wellness as the Fundamental Element for Achieving Holistic Well-Being in Older Persons: Review of Literature and Practical Application in Daily Life
    Sheng-Te Hung, Yi-Chen Cheng, Chieh-Chen Wu, Chun-Hsien Su
    Journal of Multidisciplinary Healthcare.2023; Volume 16: 1889.     CrossRef
  • Effects of Exercise, Rehabilitation, and Nutritional Approaches on Body Composition and Bone Density in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Natascia Rinaldo, Alba Pasini, Sofia Straudi, Giovanni Piva, Anna Crepaldi, Andrea Baroni, Lorenzo Caruso, Fabio Manfredini, Nicola Lamberti
    Journal of Functional Morphology and Kinesiology.2023; 8(3): 132.     CrossRef
  • Changes in Desk-Based Workers’ Sitting, Standing, and Stepping Time: Short- and Longer-Term Effects on Musculoskeletal Pain
    FRANCIS Q. S. DZAKPASU, NEVILLE OWEN, ALISON CARVER, CHRISTIAN J. BRAKENRIDGE, ELIZABETH G. EAKIN, GENEVIEVE N. HEALY, ANTHONY D. LAMONTAGNE, MARJ MOODIE, PIETER COENEN, LEON STRAKER, DAVID W. DUNSTAN
    Medicine & Science in Sports & Exercise.2023; 55(12): 2241.     CrossRef
  • Shared decision making in sarcopenia treatment
    Kang An, Zengxiang Wu, Yu Qiu, Mengjia Pan, Lin Zhang, Zhenmei An, Shuangqing Li
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Effects of combined traditional Chinese medicine therapy in patients of lower limbs injuries with osteoporosis: A retrospective paired cohort study
    Yu-Hua Lu, Chi-Hsiang Chung, Chien-Jung Lin, Li-Jen Tsai, Kuang-Chung Shih, Chieh-Hua Lu, Wu-Chien Chien
    Medicine.2023; 102(49): e36489.     CrossRef
  • The theory of planned behavior and strength training in college-aged women
    Diana Cuy Castellanos, Corinne M. Daprano, Clarissa Blevins, Anne Crecelius
    Journal of American College Health.2022; 70(3): 837.     CrossRef
  • The effect of exercise for improving bone health in cancer survivors — A systematic review and meta-analysis
    Benjamin Singh, Kellie Toohey
    Journal of Science and Medicine in Sport.2022; 25(1): 31.     CrossRef
  • The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects
    A. Mandelli, E. Tacconi, I. Levinger, G. Duque, A. Hayes
    Climacteric.2022; 25(1): 81.     CrossRef
  • Changes in blood bone markers after the first and second bouts of whole‐body eccentric exercises
    Tsang‐Hai Huang, Kazunori Nosaka, Trevor C. Chen
    Scandinavian Journal of Medicine & Science in Sports.2022; 32(3): 521.     CrossRef
  • Questions Individuals with Cardiac Conditions Engaging in Exercise often Ask Health Fitness Professionals: Research-Based Responses
    Kirk D. Hendrickson, Cindy Haskin-Popp, Barry A. Franklin
    ACSM'S Health & Fitness Journal.2022; 26(2): 29.     CrossRef
  • Effects of Different Types of Exercise on Kidney Diseases
    Hamid Arazi, Majid Mohabbat, Payam Saidie, Akram Falahati, Katsuhiko Suzuki
    Sports.2022; 10(3): 42.     CrossRef
  • Sport Activity Load and Skeletomuscular Robustness in Elite Youth Athletes
    Irina Kalabiska, Annamaria Zsakai, Dorina Annar, Robert M. Malina, Tamas Szabo
    International Journal of Environmental Research and Public Health.2022; 19(9): 5083.     CrossRef
  • A pas de deux of osteoporosis and sarcopenia: osteosarcopenia
    O. V. Yakushevskaya, S. V. Yureneva, V. I. Komedina
    Meditsinskiy sovet = Medical Council.2022; (6): 116.     CrossRef
  • The Effect of Endurance and Endurance-Strength Training on Bone Health and Body Composition in Centrally Obese Women—A Randomised Pilot Trial
    Małgorzata Jamka, Sylwia E. Piotrowska-Brudnicka, Joanna Karolkiewicz, Damian Skrypnik, Paweł Bogdański, Judyta Cielecka-Piontek, Gulnara Sultanova, Jarosław Walkowiak, Edyta Mądry
    Healthcare.2022; 10(5): 821.     CrossRef
  • Kinematic and Kinetic Characteristics of Repetitive Countermovement Jumps with Accentuated Eccentric Loading
    Micah Gross, Jan Seiler, Bastien Grédy, Fabian Lüthy
    Sports.2022; 10(5): 74.     CrossRef
  • Osteosarcopenia: A Narrative Review on Clinical Studies
    Angela Polito, Lorenzo Barnaba, Donatella Ciarapica, Elena Azzini
    International Journal of Molecular Sciences.2022; 23(10): 5591.     CrossRef
  • Efficacy of Bracing on Thoracic Kyphotic Angle and Functionality in Women with Osteoporosis: A Systematic Review
    Beatriz Sánchez-Pinto-Pinto, Carlos Romero-Morales, Daniel López-López, Carmen de-Labra, Guillermo García-Pérez-de-Sevilla
    Medicina.2022; 58(6): 693.     CrossRef
  • Are There Any Differences Between the Effect of Resistance and Aerobic Training on Spatial Learning and Memory in the Rat Model of AD?
    Khadijeh Ebrahimi, Behrouz Baghaiee
    Journal of Clinical Research in Paramedical Sciences.2022;[Epub]     CrossRef
  • Effects of Whole-Body Vibration on Breast Cancer Bone Metastasis and Vascularization in Mice
    Takeshi Matsumoto, Akihiro Mukohara
    Calcified Tissue International.2022; 111(5): 535.     CrossRef
  • Current Status of the Diagnosis and Management of Osteoporosis
    Agustín Aibar-Almazán, Ana Voltes-Martínez, Yolanda Castellote-Caballero, Diego Fernando Afanador-Restrepo, María del Carmen Carcelén-Fraile, Elena López-Ruiz
    International Journal of Molecular Sciences.2022; 23(16): 9465.     CrossRef
  • Methodological Proposal for Strength and Power Training in Older Athletes: A Narrative Review
    Emilio Jofré-Saldía, Álvaro Villalobos-Gorigoitía, Gemma Gea-García
    Current Aging Science.2022; 15(2): 135.     CrossRef
  • Robotic Walking to Mitigate Bone Mineral Density Decline and Adverse Body Composition in Individuals With Incomplete Spinal Cord Injury
    Claire Shackleton, Robert Evans, Sacha West, Wayne Derman, Yumna Albertus
    American Journal of Physical Medicine & Rehabilitation.2022; 101(10): 931.     CrossRef
  • Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia
    Chunxin Lv, Wen Shi, Teng Pan, Houshen Li, Weixiong Peng, Jiayi Xu, Jinhai Deng
    Clinical Interventions in Aging.2022; Volume 17: 1379.     CrossRef
  • Pharmacological, Nutritional, and Rehabilitative Interventions to Improve the Complex Management of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review
    Alessandro de Sire, Lorenzo Lippi, Vittorio Aprile, Dario Calafiore, Arianna Folli, Francesco D’Abrosca, Stefano Moalli, Marco Lucchi, Antonio Ammendolia, Marco Invernizzi
    Journal of Personalized Medicine.2022; 12(10): 1626.     CrossRef
  • Resistance circuit training combined with hypoxia stimulates bone system of older adults: A randomized trial
    Alba Camacho-Cardenosa, Marta Camacho-Cardenosa, Ismael Martínez-Guardado, Alejo Leal, José María Villa Andrada, Rafael Timón
    Experimental Gerontology.2022; 169: 111983.     CrossRef
  • Effects of Strength Training on BDNF in Healthy Young Adults
    Miroslaw Babiarz, Radoslaw Laskowski, Tomasz Grzywacz
    International Journal of Environmental Research and Public Health.2022; 19(21): 13795.     CrossRef
  • Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
    Ronald W. Matheny, Alexander L. Kolb, Alyssa V. Geddis, Brandon M. Roberts
    Physiological Reports.2022;[Epub]     CrossRef
  • The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions
    Miao Zhang, Yuexuan Li, Lifei Liu, Mei Huang, Miao Wang, Jun Zou
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Physical Activity and Post-Transcriptional Regulation of Aging Decay: Modulation of Pathways in Postmenopausal Osteoporosis
    Federica Vita, Sebastiano Gangemi, Giovanni Pioggia, Fabio Trimarchi, Debora Di Mauro
    Medicina.2022; 58(6): 767.     CrossRef
  • Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review
    Anna Oniszczuk, Agnieszka Kaczmarek, Mateusz Kaczmarek, Maria Ciałowicz, Ersan Arslan, Ana Filipa Silva, Filipe Manuel Clemente, Eugenia Murawska-Ciałowicz
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Exercise and Bone Health in Cancer: Enemy or Ally?
    Alice Avancini, Giulia Benato, Anita Borsati, Luca Oliviero, Lorenzo Belluomini, Marco Sposito, Daniela Tregnago, Ilaria Trestini, Jessica Insolda, Francesca Zacchi, Elena Fiorio, Federico Schena, Michele Milella, Sara Pilotto
    Cancers.2022; 14(24): 6078.     CrossRef
  • Composite Indices of Femoral Neck Strength in Middle-Aged Inactive Subjects Vs Former Football Players
    Boutros Finianos, Gautier Zunquin, Rawad El Hage
    Journal of Clinical Densitometry.2021; 24(2): 214.     CrossRef
  • Relationship between bone strength index of the hemiparetic tibial diaphysis and muscle strength in people with chronic stroke: influence of muscle contraction type and speed
    Z. Yang, T. Miller, M. Y. C. Pang
    Osteoporosis International.2021; 32(5): 951.     CrossRef
  • Effect of 12 months of creatine supplementation and whole-body resistance training on measures of bone, muscle and strength in older males
    Darren G Candow, Philip D Chilibeck, Julianne Gordon, Emelie Vogt, Tim Landeryou, Mojtaba Kaviani, Lisa Paus-Jensen
    Nutrition and Health.2021; 27(2): 151.     CrossRef
  • Effects of 6-Month Multimodal Physical Exercise Program on Bone Mineral Density, Fall Risk, Balance, and Gait in Patients with Alzheimer’s Disease: A Controlled Clinical Trial
    A. Silvia Puente-González, M. Carmen Sánchez-Sánchez, Eduardo J. Fernández-Rodríguez, J. Elicio Hernández-Xumet, Fausto J. Barbero-Iglesias, Roberto Méndez-Sánchez
    Brain Sciences.2021; 11(1): 63.     CrossRef
  • Resistance Training Modulates the Matrix Metalloproteinase-2 Activity in Different Trabecular Bones in Aged Rats
    Ivo Vieira de Sousa Neto, João Luiz Quaglioti Durigan, Gonçalo Carreiro de Farias Junior, Fabio Henrique Bogni, Amanda Lima Ruivo, Juliana Oliveira de Araújo, Keico Okino Nonaka, Heloísa Selistre-de-Araújo, Rita de Cássia Marqueti
    Clinical Interventions in Aging.2021; Volume 16: 71.     CrossRef
  • Resistance Exercise in Prostate Cancer Patients: a Short Review
    Andrej Zdravkovic, Timothy Hasenoehrl, Richard Crevenna
    Current Physical Medicine and Rehabilitation Reports.2021; 9(1): 32.     CrossRef
  • Sturz, Sarkopenie und Osteoporose
    Marcus Köller
    Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen.2021; 28(1): 19.     CrossRef
  • Effects of marathon race on selected myokines and sclerostin in middle-aged male amateur runners
    Ewa Śliwicka, Tomasz Cisoń, Łucja Pilaczyńska-Szcześniak, Andrzej Ziemba, Anna Straburzyńska-Lupa
    Scientific Reports.2021;[Epub]     CrossRef
  • Lower extremity joint loading during Bounce rope skip in comparison to run and walk
    Rajani Mullerpatan, Triveni Shetty, Yuvraj Singh, Bela Agarwal
    Journal of Bodywork and Movement Therapies.2021; 26: 1.     CrossRef
  • Powerlifting exercise performance and muscle mass indices and their relationship with bone mineral density
    Daniel A. Hackett, Angelo Sabag
    Sport Sciences for Health.2021; 17(3): 735.     CrossRef
  • Physical Activity and Bone Health in Men: A Systematic Review and Meta-Analysis
    Maureen C. Ashe, Isis Kelly dos Santos, Nicola Y. Edward, Laura A. Burnett, Rosanne Barnes, Lena Fleig, Joseph H. Puyat, Joanna E. M. Sale, Heather A. McKay, Lora M Giangregorio
    Journal of Bone Metabolism.2021; 28(1): 27.     CrossRef
  • Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people
    J. Barnsley, G. Buckland, P. E. Chan, A. Ong, A. S. Ramos, M. Baxter, F. Laskou, E. M. Dennison, C. Cooper, Harnish P. Patel
    Aging Clinical and Experimental Research.2021; 33(4): 759.     CrossRef
  • Sarcopenia and Bone Mass Loss as Risks during Aging on Female Elderly with Light Activity
    Yoni Astuti, Zulkhah Noor, Rahmah Rahmah
    Open Access Macedonian Journal of Medical Sciences.2021; 9(T4): 168.     CrossRef
  • Effect of intradialytic exercise on bone profile in hemodialysis patients
    Howaida Abdelhameed Elshinnawy, Ahmed Mohamed Bakr Bakr Mohamed, Dina Abou Bakr Farrag, Moustafa Abd Elnassier AbdElgawad
    Egyptian Rheumatology and Rehabilitation.2021;[Epub]     CrossRef
  • Osteoporosis guidelines from a rehabilitation perspective: systematic analysis and quality appraisal using AGREE II
    Giovanni IOLASCON, Alessandro de SIRE, Claudio CURCI, Marco PAOLETTA, Sara LIGUORI, Dario CALAFIORE, Francesca GIMIGLIANO, Antimo MORETTI
    European Journal of Physical and Rehabilitation Medicine.2021;[Epub]     CrossRef
  • A Case Study of an 87-Year-Old Male Bodybuilder with Complex Health Conditions
    Daniel A. Hackett, Lachlan Mitchell, Guy C. Wilson, Trinidad Valenzuela, Matthew Hollings, Maria Fiatarone Singh
    Medicina.2021; 57(7): 664.     CrossRef
  • Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19
    Quan She, Bo Chen, Wen Liu, Min Li, Weihong Zhao, Jianqing Wu
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation
    Alessandro de Sire, Marco Invernizzi, Alessio Baricich, Lorenzo Lippi, Antonio Ammendolia, Federico Alberto Grassi, Massimiliano Leigheb
    World Journal of Orthopedics.2021; 12(7): 456.     CrossRef
  • International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
    Mikel Izquierdo, R.A. Merchant, J.E. Morley, S.D. Anker, I. Aprahamian, H. Arai, M. Aubertin-Leheudre, R. Bernabei, E.L. Cadore, M. Cesari, L.-K. Chen, P. de Souto Barreto, G. Duque, L. Ferrucci, R.A. Fielding, A. García-Hermoso, L.M. Gutiérrez-Robledo, S
    The Journal of nutrition, health and aging.2021; 25(7): 824.     CrossRef
  • Intra-bone nuclear DNA variability and STR typing success in Second World War first ribs
    Laura Božič, Tajda Benedik Bevc, Eva Podovšovnik, Tomaž Zupanc, Irena Zupanič Pajnič
    International Journal of Legal Medicine.2021; 135(6): 2199.     CrossRef
  • Can Resistance Exercise Be a Tool for Healthy Aging in Post-Menopausal Women with Type 1 Diabetes?
    Zeinab Momeni, Jessica E. Logan, Ronald J. Sigal, Jane E. Yardley
    International Journal of Environmental Research and Public Health.2021; 18(16): 8716.     CrossRef
  • Role of the Myokine Irisin on Bone Homeostasis: Review of the Current Evidence
    Amanda Kornel, Danja J. Den Hartogh, Panagiota Klentrou, Evangelia Tsiani
    International Journal of Molecular Sciences.2021; 22(17): 9136.     CrossRef
  • Prevalence and Correlates of Muscle-Strengthening Activity Participation in Croatia: A Cross-Sectional Study in a National Representative Sample of 4561 Adults
    Hrvoje Radašević, Jelena Čvrljak, Željko Pedišić, Danijel Jurakić
    International Journal of Environmental Research and Public Health.2021; 18(17): 8905.     CrossRef
  • Intra-bone nuclear DNA variability and STR typing success in Second World War 12th thoracic vertebrae
    Tajda Benedik Bevc, Laura Božič, Eva Podovšovnik, Tomaž Zupanc, Irena Zupanič Pajnič
    Forensic Science International: Genetics.2021; 55: 102587.     CrossRef
  • Vascular Ageing and Aerobic Exercise
    Michaela Kozakova, Carlo Palombo
    International Journal of Environmental Research and Public Health.2021; 18(20): 10666.     CrossRef
  • Efficacy of Creatine Supplementation and Resistance Training on Area and Density of Bone and Muscle in Older Adults
    DARREN G. CANDOW, PHILIP D. CHILIBECK, JULIANNE J. GORDON, SAIJA KONTULAINEN
    Medicine & Science in Sports & Exercise.2021; 53(11): 2388.     CrossRef
  • Perspectives of personalized approach to prevention and treatment of anticonvulsant-induced osteoporosis via action on vitamin D exchange and VDR expression
    E. A. Dontseva, V. V. Trefilova, T. E. Popova, M. M. Petrova, M. Al-Zamil
    Personalized Psychiatry and Neurology.2021; 1(2): 46.     CrossRef
  • Bone health in adolescence
    Maria R. AMBROSIO, Ludovica ALIBERTI, Irene GAGLIARDI, Paola FRANCESCHETTI, Maria C. ZATELLI
    Minerva Obstetrics and Gynecology.2021;[Epub]     CrossRef
  • To Evaluate the Awareness and Prevention of Osteoporosis in Patients Attending Orthopaedics Outdoor Clinics in a Tertiary Level Hospital
    Annie Sandhu, Dharminder Singh, Akashdeep Singh, Kuldip Singh Sand
    Trends in Medical Research.2021; 16(2): 73.     CrossRef
  • Novel Insights into the Pathogenesis of Spinal Sarcopenia and Related Therapeutic Approaches: A Narrative Review
    Yu-Kai Kuo, Yu-Ching Lin, Ching-Yu Lee, Chih-Yu Chen, Jowy Tani, Tsung-Jen Huang, Hsi Chang, Meng-Huang Wu
    International Journal of Molecular Sciences.2020; 21(8): 3010.     CrossRef
  • Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus
    V.A. Shahen, M. Gerbaix, S. Koeppenkastrop, S.F. Lim, K.E. McFarlane, Amanda N.L. Nguyen, X.Y. Peng, N.B. Weiss, T.C. Brennan-Speranza
    Cytokine & Growth Factor Reviews.2020; 55: 109.     CrossRef
  • Effect of pre-treatment of strength training and raloxifene in periestropause on bone healing
    Melise Jacon Peres-Ueno, Fernanda Fernandes, Victor Gustavo Balera Brito, Ângela Cristina Nicola, Camila Tami Stringhetta-Garcia, Robson Chacon Castoldi, Amanda Pinatti Menezes, Paulo Cézar Ciarlini, Mário Jeferson Quirino Louzada, Sandra Helena Penha Oli
    Bone.2020; 134: 115285.     CrossRef
  • Physical rehabilitation of patients with osteoporosis
    E.D. Yehudina, O.S. Kalashnikova
    Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury.2020; 97(2): 78.     CrossRef
  • RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling
    Mohammad Tobeiha, Mohammed H. Moghadasian, Negin Amin, Sadegh Jafarnejad
    BioMed Research International.2020; 2020: 1.     CrossRef
  • Effects of muscular strength training and growth hormone (GH) supplementation on femoral bone tissue: analysis by Raman spectroscopy, dual-energy X-ray absorptiometry, and mechanical resistance
    Robson Chacon Castoldi, Guilherme Akio Tamura Ozaki, Thiago Alves Garcia, Ines Cristina Giometti, Tatiana Emy Koike, Regina Celi Trindade Camargo, João Domingos Augusto dos Santos Pereira, Carlos José Leopoldo Constantino, Mário Jefferson Quirino Louzada,
    Lasers in Medical Science.2020; 35(2): 345.     CrossRef
  • Approaches to the diagnosis and prevention of frailty
    S. J. Woolford, O. Sohan, E. M. Dennison, C. Cooper, H. P. Patel
    Aging Clinical and Experimental Research.2020; 32(9): 1629.     CrossRef
  • The Impact of Exercise on Bone Health in Type 2 Diabetes Mellitus—a Systematic Review
    R. Viggers, Z. Al-Mashhadi, R. Fuglsang-Nielsen, S. Gregersen, J. Starup-Linde
    Current Osteoporosis Reports.2020; 18(4): 357.     CrossRef
  • Transformation of Mature Osteoblasts into Bone Lining Cells and RNA Sequencing-Based Transcriptome Profiling of Mouse Bone during Mechanical Unloading
    A Ram Hong, Kwangsoo Kim, Ji Yeon Lee, Jae-Yeon Yang, Jung Hee Kim, Chan Soo Shin, Sang Wan Kim
    Endocrinology and Metabolism.2020; 35(2): 456.     CrossRef
  • Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly
    Sandra Amatriain-Fernández, Thomas Gronwald, Eric Murillo-Rodríguez, Claudio Imperatori, Alexandre Francisco Solano, Alexandra Latini, Henning Budde
    Frontiers in Medicine.2020;[Epub]     CrossRef
  • Osteosarcopenia: beyond age-related muscle and bone loss
    Gabriela Fagundes Belchior, Ben Kirk, Evela Aparecida Pereira da Silva, Gustavo Duque
    European Geriatric Medicine.2020; 11(5): 715.     CrossRef
  • Mediating role of physical fitness and fat mass on the associations between physical activity and bone health in youth
    Duarte Henriques-Neto, João Pedro Magalhães, Pedro Júdice, Megan Hetherington-Rauth, Miguel Peralta, Adilson Marques, Luís B. Sardinha
    Journal of Sports Sciences.2020; 38(24): 2811.     CrossRef
  • Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies
    Daniela F. Cardoso, Elisa A. Marques, Diogo V. Leal, Aníbal Ferreira, Luke A. Baker, Alice C. Smith, João L. Viana
    BMC Nephrology.2020;[Epub]     CrossRef
  • Short and medium-term effects of a multicomponent physical exercise program with a Mediterranean diet on bone mineral density, gait, balance, and fall risk for patients with Alzheimer disease
    Ana Silvia Puente-González, Felipe Sánchez-González, Juan Elicio Hernández-Xumet, María Carmen Sánchez-Sánchez, Fausto José Barbero-Iglesias, Roberto Méndez-Sánchez
    Medicine.2020; 99(38): e22385.     CrossRef
  • Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
    Richard Kirwan, Deaglan McCullough, Tom Butler, Fatima Perez de Heredia, Ian G. Davies, Claire Stewart
    GeroScience.2020; 42(6): 1547.     CrossRef
  • Acute Effects of Two Types of Dumbbell Exercise on Oxygenated Hemodynamic Concentration of Cerebral Activation in Healthy Young Male Adults: A Functional Near-Infrared Spectroscopy Study
    Yana Wang, Jiaojiao Lü, Jifeng Rong, Linjie Song, Wei Wang, Yifan Jiang, Yu Liu, Lingyan Huang
    Frontiers in Human Neuroscience.2020;[Epub]     CrossRef
  • Muscle-Derived Lumican Stimulates Bone Formation via Integrin α2β1 and the Downstream ERK Signal
    Jin Young Lee, So Jeong Park, Da Ae Kim, Seung Hun Lee, Jung-Min Koh, Beom-Jun Kim
    Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
  • Analysis of Age-Based Bone Mineral Density in the Korean Adult Population Using Dual-Energy X-ray Absorptiometry
    Jung Chul Lee, Chong Hoon Lee, Dong Wha Chung, Hee Joo Lee, Jae Yong Park
    Applied Sciences.2020; 10(23): 8469.     CrossRef
  • Preventive Moderate Continuous Running-Exercise Conditioning Improves the Healing of Non-Critical Size Bone Defects in Male Wistar Rats: A Pilot Study Using µCT
    Céline Bourzac, Morad Bensidhoum, Mathieu Manassero, Christine Chappard, Nicolas Michoux, Stéphane Pallu, Hugues Portier
    Life.2020; 10(12): 308.     CrossRef
  • BONE MINERAL DENSITY: AN ANALYSIS OF WEIGHT BEARING, RESISTANCE AND IMPACT PHYSICAL ACTIVITIES
    Arvind Malik, Sonia Malik, Vishal Dahiya
    PARIPEX INDIAN JOURNAL OF RESEARCH.2020; : 1.     CrossRef
  • Effects of ursolic acid on muscle mass and bone microstructure in rats with casting-induced muscle atrophy
    Yun Seok Kang, Eun Bi Noh, Sang Hyun Kim
    Journal of Exercise Nutrition & Biochemistry.2019; 23(3): 45.     CrossRef
  • Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
    Emanuela A. Greco, Peter Pietschmann, Silvia Migliaccio
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Associations of Health-Related Quality of Life, Fear of Falling and Objective Measures of Physical Function with Bone Health in Postmenopausal Women with Low Bone Mass
    Gandham, McMillan, Ng, Humbert, Bonham, Zengin, Ebeling, Scott
    Journal of Clinical Medicine.2019; 8(9): 1370.     CrossRef
  • Osteoblasts are “educated” by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment
    Alexus D. Kolb, Alison B. Shupp, Dimpi Mukhopadhyay, Frank C. Marini, Karen M. Bussard
    Breast Cancer Research.2019;[Epub]     CrossRef
Close layer
Miscellaneous
Parathyroid Hormone-Related Protein in the Hand or Out of Hand?
Sang Wan Kim
Endocrinol Metab. 2018;33(2):202-203.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.202
  • 2,653 View
  • 31 Download
PDFPubReader   ePub   
Close layer
Clinical Study
Characteristics of Korean Patients with Primary Adrenal Insufficiency: A Registry-Based Nationwide Survey in Korea
A Ram Hong, Ohk-Hyun Ryu, Seong Yeon Kim, Sang Wan Kim
Endocrinol Metab. 2017;32(4):466-474.   Published online December 14, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.4.466
  • 5,734 View
  • 64 Download
  • 14 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

Primary adrenal insufficiency (PAI) is a rare, potentially life-threatening condition. There are few Korean studies on PAI, and most have had small sample sizes. We aimed to examine the etiology, clinical characteristics, treatment, and mortality of PAI in Korean patients.

Methods

A nationwide, multicenter, registry-based survey was conducted to identify adults diagnosed with or treated for PAI at 30 secondary or tertiary care institutions in Korea between 2000 and 2014.

Results

A total of 269 patients with PAI were identified. The prevalence of PAI was 4.17 per million. The estimated incidence was 0.45 per million per year. The mean age at diagnosis was 49.0 years, and PAI was more prevalent in men. Adrenal tuberculosis was the most common cause of PAI in patients diagnosed before 2000; for those diagnosed thereafter, adrenal metastasis and tuberculosis were comparable leading causes. The etiology of PAI was not identified in 34.9% of cases. Of the patients receiving glucocorticoid replacement therapy, prednisolone was more frequently administered than hydrocortisone (69.4% vs. 26.5%, respectively), and only 27.1% of all patients received fludrocortisone. We observed an increased prevalence of metabolic disease and osteoporosis during the follow-up period (median, 60.2 months). The observed overall mortality and disease-specific mortality rates were 11.9% and 3.1%, respectively.

Conclusion

The prevalence of PAI is significantly lower in Koreans than in reports from Western countries. The high frequency undetermined etiology in patients with PAI suggests the need to reveal accurate etiology of PAI in Korea.

Citations

Citations to this article as recorded by  
  • Genetic and phenotypic spectrum of non-21-hydroxylase-deficiency primary adrenal insufficiency in childhood: data from 111 Chinese patients
    Ying Duan, Wanqi Zheng, Yu Xia, Huiwen Zhang, Lili Liang, Ruifang Wang, Yi Yang, Kaichuang Zhang, Deyun Lu, Yuning Sun, Lianshu Han, Yongguo Yu, Xuefan Gu, Yu Sun, Bing Xiao, Wenjuan Qiu
    Journal of Medical Genetics.2024; 61(1): 27.     CrossRef
  • Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults
    Marianne Øksnes, Eystein S Husebye
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): 269.     CrossRef
  • Epidemiology and Causes of Primary Adrenal Insufficiency in Children: A Population-Based Study
    Joonatan Borchers, Eero Pukkala, Outi Mäkitie, Saila Laakso
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): 2879.     CrossRef
  • Primary Adrenal Insufficiency in Acute Progressive Systemic Inflammation Accompanied by Latent Tuberculosis: A Case Report
    Kasumi Nishikawa, Mizuki Nitta, Shoma Tanaka, Chiaki Sano, Ryuichi Ohta
    Cureus.2023;[Epub]     CrossRef
  • What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study
    S. Puglisi, A. Rossini, I. Tabaro, S. Cannavò, F. Ferrau’, M. Ragonese, G. Borretta, M. Pellegrino, F. Dughera, A. Parisi, A. Latina, A. Pia, M. Terzolo, G. Reimondo
    Journal of Endocrinological Investigation.2021; 44(4): 865.     CrossRef
  • Adrenal insufficiency
    Eystein S Husebye, Simon H Pearce, Nils P Krone, Olle Kämpe
    The Lancet.2021; 397(10274): 613.     CrossRef
  • Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion
    A. M. Isidori, G. Arnaldi, M. Boscaro, A. Falorni, C. Giordano, R. Giordano, R. Pivonello, C. Pozza, E. Sbardella, C. Simeoli, C. Scaroni, A. Lenzi
    Journal of Endocrinological Investigation.2020; 43(5): 683.     CrossRef
  • Novel ABCD1 Gene Mutation in a Korean Patient with X-Linked Adrenoleukodystrophy Presenting with Addison's Disease
    Yun Kyung Cho, Seo-Young Lee, Sang-Wook Kim
    Endocrinology and Metabolism.2020; 35(1): 188.     CrossRef
  • Encountering COVID-19 as Endocrinologists
    Eun-Jung Rhee, Jung Hee Kim, Sun Joon Moon, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(2): 197.     CrossRef
  • Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
    Kathrin R Frey, Tina Kienitz, Julia Schulz, Manfred Ventz, Kathrin Zopf, Marcus Quinkler
    Endocrine Connections.2018; 7(6): 811.     CrossRef
  • The potential role for infections in the pathogenesis of autoimmune Addison’s disease
    A Hellesen, E Bratland
    Clinical and Experimental Immunology.2018; 195(1): 52.     CrossRef
  • Evaluation and Treatment of Adrenal Dysfunction in the Primary Care Environment
    Shannon Cole
    Nursing Clinics of North America.2018; 53(3): 385.     CrossRef
Close layer
Clinical Guidelines for the Management of Adrenal Incidentaloma
Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang Wan Kim, Soo-Kyung Kim, Hae Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
Endocrinol Metab. 2017;32(2):200-218.   Published online June 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.200
  • 16,263 View
  • 692 Download
  • 80 Web of Science
  • 78 Crossref
AbstractAbstract PDFPubReader   

An adrenal incidentaloma is an adrenal mass found in an imaging study performed for other reasons unrelated to adrenal disease and often accompanied by obesity, diabetes, or hypertension. The prevalence and incidence of adrenal incidentaloma increase with age and are also expected to rise due to the rapid development of imaging technology and frequent imaging studies. The Korean Endocrine Society is promoting an appropriate practice guideline to meet the rising incidence of adrenal incidentaloma, in cooperation with the Korean Adrenal Gland and Endocrine Hypertension Study Group. In this paper, we discuss important core issues in managing the patients with adrenal incidentaloma. After evaluating core proposition, we propose the most critical 20 recommendations from the initially organized 47 recommendations by Delphi technique.

Citations

Citations to this article as recorded by  
  • The improvement of postoperative blood pressure and associated factors in patients with hormone‐negative adrenal adenoma and hypertension
    Jiaxing Sun, Yingchun Dong, Hanbo Wang, Xudong Guo, Ning Suo, Shangjian Li, Xiangbin Ren, Shaobo Jiang
    Journal of Surgical Oncology.2024; 129(6): 1073.     CrossRef
  • Clinical features and treatment options for pediatric adrenal incidentalomas: a retrospective single center study
    Xiaojiang Zhu, Saisai Liu, Yimin Yuan, Nannan Gu, Jintong Sha, Yunfei Guo, Yongji Deng
    BMC Pediatrics.2024;[Epub]     CrossRef
  • Characterizing incidental mass lesions in abdominal dual-energy CT compared to conventional contrast-enhanced CT
    Jack Junchi Xu, Peter Sommer Ulriksen, Camilla Wium Bjerrum, Michael Patrick Achiam, Timothy Andrew Resch, Lars Lönn, Kristoffer Lindskov Hansen
    Acta Radiologica.2023; 64(3): 945.     CrossRef
  • Metastatic Adrenal PEComa: Case Report and Short Review of the Literature
    Enrico Battistella, Luca Pomba, Marica Mirabella, Michele Gregianin, Antonio Scapinello, Marco Volante, Antonio Toniato
    Medicina.2023; 59(1): 149.     CrossRef
  • Surgical management and outcomes of spinal metastasis of malignant adrenal tumor: A retrospective study of six cases and literature review
    Xiangzhi Ni, Jing Wang, Jiashi Cao, Kun Zhang, Shuming Hou, Xing Huang, Yuanjin Song, Xin Gao, Jianru Xiao, Tielong Liu
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • An adrenal incidentaloma that had appeared to produce dehydroepiandrosterone-sulfate in excess before immunohistochemical study of the tumor
    Toshihide Yamamoto, Takuma Kimura, Yuki Kubo, Shin-ichi Nakatsuka, Hiromasa Harada, Takashi Suzuki, Hironobu Sasano
    Endocrine Journal.2023; 70(1): 43.     CrossRef
  • Mortality Not Increased in Patients With Nonfunctional Adrenal Adenomas: A Matched Cohort Study
    Albin Kjellbom, Ola Lindgren, Malin Danielsson, Henrik Olsen, Magnus Löndahl
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(8): e536.     CrossRef
  • Construction of a novel clinical nomogram to predict cancer-specific survival in patients with primary malignant adrenal tumors: a large population-based retrospective study
    Mingzhen Li, Xiaoying Duan, Di You, Linlin Liu
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Primary Aldosteronism Prevalence – An Unfolding Story
    Suranut Charoensri, Adina F. Turcu
    Experimental and Clinical Endocrinology & Diabetes.2023; 131(07/08): 394.     CrossRef
  • Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
    Alexandra-Ioana Trandafir, Mihaela Stanciu, Simona Elena Albu, Vasile Razvan Stoian, Irina Ciofu, Cristian Persu, Claudiu Nistor, Mara Carsote
    Journal of Clinical Medicine.2023; 12(13): 4244.     CrossRef
  • Clinical manifestations of functionally autonomous cortisol secretion in patients with adrenal masse
    T. R. Chzhen, T. P. Kiseleva
    Ural Medical Journal.2023; 22(3): 13.     CrossRef
  • Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature?
    M. Caputo, T. Daffara, A. Ferrero, M. Romanisio, E. Monti, C. Mele, M. Zavattaro, S. Tricca, A. Siani, A. Clemente, C. Palumbo, S. De Cillà, A. Carriero, A. Volpe, P. Marzullo, G. Aimaretti, F. Prodam
    Journal of Endocrinological Investigation.2023; 47(2): 377.     CrossRef
  • Adrenal ganglioneuroma: Features and outcomes of cases series
    Pei Li, Rongchang Zhang, Guang Wang, Jiongming Li
    Asian Journal of Surgery.2023; 46(11): 5272.     CrossRef
  • Recent Updates on the Management of Adrenal Incidentalomas
    Seung Shin Park, Jung Hee Kim
    Endocrinology and Metabolism.2023; 38(4): 373.     CrossRef
  • Adrenal malakoplakia a rare lesion that mimics a neoplasm
    Orión Erenhú Rodríguez González, Jesus Eduardo Osorio, Edgar Iván Bravo Castro
    Urology Case Reports.2023; 51: 102568.     CrossRef
  • LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines
    Jongsung Noh, Chaelin Lee, Jung Hee Kim, Seung Woon Myung, Man Ho Choi
    Journal of Lipid Research.2023; 64(11): 100453.     CrossRef
  • Incidentaloma adrenal. Del hallazgo casual al diagnóstico definitivo
    Mercedes Retamal Ortíz, Ana Belén Vicario Parada, Elena Vázquez Jarén
    Actualización en Medicina de Familia.2023;[Epub]     CrossRef
  • Diagnosis and management of adrenal incidentaloma: use of clinical judgment and evidence in dialog with the patient
    Yusaku Yoshida, Kiyomi Horiuchi, Michio Otsuki, Takahiro Okamoto
    Surgery Today.2023;[Epub]     CrossRef
  • Can MDCT Enhancement Patterns Be Helpful in Differentiating Secretory from Non-Functional Adrenal Adenoma?
    Svetlana Kocic, Vladimir Vukomanovic, Aleksandar Djukic, Jovica Saponjski, Dusan Saponjski, Vuk Aleksic, Vesna Ignjatovic, Katarina Vuleta Nedic, Vladan Markovic, Radisa Vojinovic
    Medicina.2023; 60(1): 72.     CrossRef
  • Computer-assisted Reporting and Decision Support Increases Compliance with Follow-up Imaging and Hormonal Screening of Adrenal Incidentalomas
    Renata R. Almeida, Bernardo C. Bizzo, Ramandeep Singh, Katherine P. Andriole, Tarik K. Alkasab
    Academic Radiology.2022; 29(2): 236.     CrossRef
  • Incidental Adrenal Masses: Adherence to Guidelines and Methods to Improve Initial Follow-Up: A Systematic Review
    Timothy Feeney, Andrea Madiedo, Philip E. Knapp, Avneesh Gupta, David McAneny, Frederick Thurston Drake
    Journal of Surgical Research.2022; 269: 18.     CrossRef
  • Incidental Adrenal Lesions May Not Always Require Further Imaging Work-up
    Deborah A. Baumgarten
    Radiology.2022; 302(1): 138.     CrossRef
  • Adrenal Nodules Detected at Staging CT in Patients with Resectable Gastric Cancers Have a Low Incidence of Malignancy
    Hae Young Kim, Won Chang, Yoon Jin Lee, Ji Hoon Park, Jungheum Cho, Hee Young Na, Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, Young Hoon Kim, Kyoung Ho Lee
    Radiology.2022; 302(1): 129.     CrossRef
  • Management of incidental adrenal nodules: a survey of abdominal radiologists conducted by the Society of Abdominal Radiology Disease-Focused Panel on Adrenal Neoplasms
    Michael T. Corwin, Nicola Schieda, Erick M. Remer, Elaine M. Caoili
    Abdominal Radiology.2022; 47(4): 1360.     CrossRef
  • Primary hyperaldosteronism: indications for screening
    Novella M. Chikhladze
    Terapevticheskii arkhiv.2022; 94(1): 107.     CrossRef
  • Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas
    Jordan A. Higgs, Alyssa P. Quinn, Kevin D. Seely, Zeke Richards, Shad P. Mortensen, Cody S. Crandall, Amanda E. Brooks
    International Journal of Molecular Sciences.2022; 23(8): 4340.     CrossRef
  • Can Radiomics Provide Additional Diagnostic Value for Identifying Adrenal Lipid-Poor Adenomas From Non-Adenomas on Unenhanced CT?
    Binhao Zhang, Huangqi Zhang, Xin Li, Shengze Jin, Jiawen Yang, Wenting Pan, Xue Dong, Jin Chen, Wenbin Ji
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Adrenal Surgery in the Era of Multidisciplinary Endocrine Tumor Boards
    Costanza Chiapponi, Daniel Pinto Dos Santos, Milan Janis Michael Hartmann, Matthias Schmidt, Michael Faust, Roger Wahba, Christiane Josephine Bruns, Anne Maria Schultheis, Hakan Alakus
    Hormone and Metabolic Research.2022; 54(05): 294.     CrossRef
  • Optimal and novel imaging of the adrenal glands
    Patrick J. Navin, Michael R. Moynagh
    Current Opinion in Endocrinology, Diabetes & Obesity.2022; 29(3): 253.     CrossRef
  • Adrenal Tumors in Young Adults: Case Reports and Literature Review
    Małgorzata Zdrojewska, Emilia Mech-Siebieszuk, Renata Świątkowska-Stodulska, Bartosz Regent, Michał Kunc, Łukasz Zdrojewski, Krzysztof Sworczak
    Medicina.2022; 58(6): 746.     CrossRef
  • Incidence of malignancy in adrenal nodules detected on staging CTs of patients with potentially resectable colorectal cancer
    Hae Young Kim, Yoon Jin Lee, Won Chang, Ji Hoon Park, Jungheum Cho, Hyeon Jeong Oh, Young Hoon Kim, Kyoung Ho Lee
    European Radiology.2022; 32(12): 8560.     CrossRef
  • Appendiceal Incidentalomas: Prevalence, Radiographic Characteristics, Management, and Outcomes
    Adam Kelly, Stacy O’Connor, Diana Kane, Chiang-Ching Huang, Harveshp Mogal
    Annals of Surgical Oncology.2022; 29(13): 8265.     CrossRef
  • Laparoscopic large adrenal mass resection: why we should be more careful?
    Mohsen Varyani, Mahmood Parvin, Hamidreza Akbari Gilani
    African Journal of Urology.2022;[Epub]     CrossRef
  • Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
    Nadia Sawicka-Gutaj, Hanna Komarowska, Dawid Gruszczyński, Aleksandra Derwich, Anna Klimont, Marek Ruchała
    Journal of Clinical Medicine.2022; 11(19): 5563.     CrossRef
  • Application of radiomics in adrenal incidentaloma: a literature review
    Cheng Li, Yan Fu, Xiaoping Yi, Xiao Guan, Longfei Liu, Bihong T. Chen
    Discover Oncology.2022;[Epub]     CrossRef
  • Hormone-inactive adrenal tumors in clinician’s practice
    T. R. Chzhen, T. P. Kiseleva
    Perm Medical Journal.2022; 39(5): 48.     CrossRef
  • The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism
    Vendela Berndt, Per Dahlqvist, Jennie de Verdier, Henrik Ryberg, Oskar Ragnarsson
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Role of Intraoperative Indocyanine Green (ICG) and Preoperative 3-Dimensional (3D) Reconstruction in Laparoscopic Adrenalectomy: A Propensity Score-matched Analysis
    Giuseppe Palomba, Vincenza Paola Dinuzzi, Francesca Pegoraro, Roberto Ivan Troisi, Roberto Montalti, Giovanni Domenico De Palma, Giovanni Aprea
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2022; 32(6): 643.     CrossRef
  • The Etiological Profile of Adrenal Incidentalomas
    Fatima-Zahra Lahmamssi, Loubna Saadaoui, Hayat Aynaou, Houda Salhi, Hanan El Ouahabi
    Cureus.2022;[Epub]     CrossRef
  • Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
    Jong Chul Won, Ki-Hyun Baek
    Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
  • Conduite à tenir face à un fortuitome surrénalien chez le chien ou le chat
    Diane Pichard, Ghita Benckekroun
    Le Nouveau Praticien Vétérinaire canine & féline.2022; 19(82): 40.     CrossRef
  • Laparoscopic transperitoneal adrenalectomy: a comparative study of different techniques for vessel sealing
    Luca Cardinali, Edlira Skrami, Elisa Catani, Flavia Carle, Monica Ortenzi, Andrea Balla, Mario Guerrieri
    Surgical Endoscopy.2021; 35(2): 673.     CrossRef
  • Epidemiology and Comorbidity of Adrenal Cushing Syndrome: A Nationwide Cohort Study
    Chang Ho Ahn, Jung Hee Kim, Man Young Park, Sang Wan Kim
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1362.     CrossRef
  • Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review
    Marta Araujo-Castro, Pablo Valderrábano, Héctor F. Escobar-Morreale, Felicia A. Hanzu, Gregori Casals
    Endocrine.2021; 72(1): 40.     CrossRef
  • A Rare Neoplasm: Primary Adrenal Leiomyosarcoma
    Jack T. Barnett, Christine W. Liaw, Reza Mehrazin
    Urology.2021; 148: e11.     CrossRef
  • Adrenal Ganglioneuroma Presenting as an Incidentaloma in an Adolescent Patient
    Sonia G. Sharma, Steven N. Levine, Xin Gu
    AACE Clinical Case Reports.2021; 7(1): 61.     CrossRef
  • Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series
    Jeongmin Lee, Jeonghoon Ha, Sang-Kuon Lee, Hye Lim Park, Sung-Hoon Kim, Dong-Jun Lim, Jung Min Lee, Sang-Ah Chang, Moo Il Kang, Min-Hee Kim
    International Journal of General Medicine.2021; Volume 14: 673.     CrossRef
  • Best Achievements in Pituitary and Adrenal Diseases in 2020
    Chang Ho Ahn, Jung Hee Kim
    Endocrinology and Metabolism.2021; 36(1): 51.     CrossRef
  • Adrenal surgery: Review of 35 years experience in a single centre
    Enrico Battistella, Stefania Ferrari, Luca Pomba, Antonio Toniato
    Surgical Oncology.2021; 37: 101554.     CrossRef
  • Adrenocortical Carcinoma: A Case of Missed Diagnosis
    Yusef Hazimeh, Carlie Sigel, Carsello Carie, Mathew Leinung, Zaynab Khalaf
    Cureus.2021;[Epub]     CrossRef
  • Imagerie fonctionnelle en endocrinologie : nouveaux paradigmes à l’horizon 2020
    E. Marchal
    Médecine Nucléaire.2021; 45(3): 158.     CrossRef
  • Adrenal Incidentaloma
    Caren G. Solomon, Electron Kebebew
    New England Journal of Medicine.2021; 384(16): 1542.     CrossRef
  • Can Hematological Parameters Play a Role in the Differential Diagnosis of Adrenal Tumors?
    Mehmet Gürkan Arıkan, Göktan Altuğ Öz, Nur Gülce İşkan, Necdet Süt, İlkan Yüksel, Ersan Arda
    Uro.2021; 1(2): 39.     CrossRef
  • Incidental Adrenal Nodules
    Daniel I. Glazer, Michael T. Corwin, William W. Mayo-Smith
    Radiologic Clinics of North America.2021; 59(4): 591.     CrossRef
  • Antioxidant Barrier and Oxidative Damage to Proteins, Lipids, and DNA/RNA in Adrenal Tumor Patients
    Barbara Choromańska, Piotr Myśliwiec, Tomasz Kozłowski, Magdalena Łuba, Piotr Wojskowicz, Jacek Dadan, Hanna Myśliwiec, Katarzyna Choromańska, Anna Gibała, Anna Starzyńska, Małgorzata Żendzian-Piotrowska, Anna Zalewska, Mateusz Maciejczyk, Jos L. Quiles
    Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
  • Laparoscopic Retroperitoneoscopic Removal of an Adrenal Hemangioma: a Case Report
    Kristin McCoy, Katherine Howe, Daniel Tershak
    Journal of Endocrine Surgery.2021; 21(3): 70.     CrossRef
  • Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea
    Eu Jeong Ku, Chaelin Lee, Jaeyoon Shim, Sihoon Lee, Kyoung-Ah Kim, Sang Wan Kim, Yumie Rhee, Hyo-Jeong Kim, Jung Soo Lim, Choon Hee Chung, Sung Wan Chun, Soon-Jib Yoo, Ohk-Hyun Ryu, Ho Chan Cho, A Ram Hong, Chang Ho Ahn, Jung Hee Kim, Man Ho Choi
    Endocrinology and Metabolism.2021; 36(5): 1131.     CrossRef
  • Cross-Talk Between Nitrosative Stress, Inflammation and Hypoxia-Inducible Factor in Patients with Adrenal Masses
    Barbara Choromańska, Piotr Myśliwiec, Tomasz Kozłowski, Magdalena Łuba, Piotr Wojskowicz, Jacek Dadan, Hanna Myśliwiec, Katarzyna Choromańska, Katarzyna Makarewicz, Anna Zalewska, Mateusz Maciejczyk
    Journal of Inflammation Research.2021; Volume 14: 6317.     CrossRef
  • Cirugía laparoscópica en incidentaloma suprarrenal para el cirujano general: serie de casos
    Martín Adrián Bolívar-Rodríguez, Marcel Antonio Cázarez-Aguilar, Pedro Alejandro Magaña-Zavala, Francisco Magaña-Olivas, José Martín Niebla-Moreno
    Revista Mexicana de Cirugía Endoscópica.2021; 22(1): 8.     CrossRef
  • Adrenal adenomas: what to do with them? Review 2
    S. Rybakov
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(3): 241.     CrossRef
  • Is Follow-up of Adrenal Incidentalomas Always Mandatory?
    Giuseppe Reimondo, Alessandra Muller, Elisa Ingargiola, Soraya Puglisi, Massimo Terzolo
    Endocrinology and Metabolism.2020; 35(1): 26.     CrossRef
  • Imaging Findings of Primary Adrenal Leiomyosarcoma: A Case Report
    Hye Ran Yoon, Dong Hee Park
    Journal of the Korean Society of Radiology.2020; 81(2): 459.     CrossRef
  • WFUMB position paper on the management incidental findings: adrenal incidentaloma
    Christoph F. Dietrich, Jean Michel Correas, Yi Dong, Christian Nolsoe, Susan Campbell Westerway, Christian Jenssen
    Ultrasonography.2020; 39(1): 11.     CrossRef
  • A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features
    Takamasa Ichijo, Hajime Ueshiba, Hajime Nawata, Toshihiko Yanase
    Endocrine Journal.2020; 67(2): 141.     CrossRef
  • Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI
    Khaled M. Elsayes, Mohab M. Elmohr, Sanaz Javadi, Christine O. Menias, Erick M. Remer, Ajaykumar C. Morani, Akram M. Shaaban
    Abdominal Radiology.2020; 45(4): 982.     CrossRef
  • Adrenal Incidentaloma
    Mark Sherlock, Andrew Scarsbrook, Afroze Abbas, Sheila Fraser, Padiporn Limumpornpetch, Rosemary Dineen, Paul M Stewart
    Endocrine Reviews.2020; 41(6): 775.     CrossRef
  • A Web Application for Adrenal Incidentaloma Identification, Tracking, and Management Using Machine Learning
    Wasif Bala, Jackson Steinkamp, Timothy Feeney, Avneesh Gupta, Abhinav Sharma, Jake Kantrowitz, Nicholas Cordella, James Moses, Frederick Thurston Drake
    Applied Clinical Informatics.2020; 11(04): 606.     CrossRef
  • Presentation and outcome of patients with an adrenal mass: A retrospective observational study
    Nadeema Rafiq, Tauseef Nabi, SajadAhmad Dar, Shahnawaz Rasool
    Clinical Cancer Investigation Journal.2020; 9(5): 198.     CrossRef
  • Evaluation of Functionality and Growth Rates in Adrenal Incidentalomas: Single Center Experience
    Suna AVCI, Yüksel Aslı OZTURKMEN, Sayid ZUHUR, Gulkan OZKAN, Elif GUVEN, Nazan DEMİR, Yuksel ALTUNTAS
    Phoenix Medical Journal.2020; 2(3): 125.     CrossRef
  • Percutaneous Adrenal Radiofrequency Ablation: A Short Review for Endocrinologists
    Byung Kwan Park
    Endocrinology and Metabolism.2020; 35(4): 750.     CrossRef
  • Autonomous cortisol secretion in adrenal incidentalomas
    Marta Araujo-Castro, Miguel Antonio Sampedro Núñez, Mónica Marazuela
    Endocrine.2019; 64(1): 1.     CrossRef
  • Primary adrenal schwannoma: a series of 31 cases emphasizing their clinicopathologic features and favorable prognosis
    Jun Zhou, Dandan Zhang, Wencai Li, Luting Zhou, Haimin Xu, Saifang Zheng, Chaofu Wang
    Endocrine.2019; 65(3): 662.     CrossRef
  • Challenging risk factors for right and left laparoscopic adrenalectomy: A single centre experience with 272 cases
    Kadir Omur Gunseren, Mehmet Cagatay Cicek, Hakan Vuruskan, Yakup Kordan, Ismet Yavascaoglu
    International braz j urol.2019; 45(4): 747.     CrossRef
  • A case report on 111In chloride bone marrow scintigraphy in management of adrenal myelolipoma
    Tatsuya Yamamoto, Mitsuru Koizumi, Atsushi Kohno, Noboru Numao, Kentaro Inamura
    Medicine.2019; 98(8): e14625.     CrossRef
  • PRACTICAL ASPECTS OF LAPAROSCOPIC ADRENALECTOMY IN CHILDREN WITH BENIGN ADRENAL TUMORS
    I. V. Poddubny, R. S. Oganesyan, K. N. Tolstov, M. A. Kareva
    Russian Journal of Pediatric Surgery.2019; 23(5): 248.     CrossRef
  • Incidental neuroblastoma with bilateral retinoblastoma: what are the chances?
    Kelsey Roelofs, Furqan Shaikh, William Astle, Brenda L. Gallie, Sameh E. Soliman
    Ophthalmic Genetics.2018; 39(3): 410.     CrossRef
  • Surgical Considerations in Subclinical Cushing’s Syndrome. When is it Time to Operate?
    Alexander M. Nixon, C Aggeli, C Tserkezis, GN Zografos
    Hellenic Journal of Surgery.2018; 90(1): 27.     CrossRef
  • Adrenal incidentaloma – diagnostic and treating problem – own experience
    Ryszard Pogorzelski, Krzysztof Celejewski, Sadegh Toutounchi, Ewa Krajewska, Tomasz Wołoszko, Małgorzata Szostek, Wawrzyniec Jakuczun, Patryk Fiszer, Małgorzata Legocka, Zbigniew Gałązka
    Open Medicine.2018; 13(1): 281.     CrossRef
Close layer
Clinical Study
Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
Jung Hee Kim, Kyeong Seon Park, A Ram Hong, Chan Soo Shin, Seong Yeon Kim, Sang Wan Kim
Endocrinol Metab. 2016;31(2):277-283.   Published online May 13, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.277
  • 5,306 View
  • 53 Download
  • 14 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   
Background

Diagnosis of primary aldosteronism (PA) begins with aldosterone-to-renin ratio (ARR) measurement followed by confirmative tests. However, the ARR has high false positive rates which led to unnecessary confirmatory tests. Captopril challenge test (CCT) has been used as one of confirmatory tests, but the accuracy of it in the diagnosis of PA is still controversial. We aimed to examine the clinical efficacy of CCT as a post-screening test in PA.

Methods

In a prospective study, we enrolled subjects with suspected PA who had hypertension and ARR >20 (ng/dL)/(ng/mL/hr). Sixty-four patients who underwent both the saline infusion test and the CCT were included.

Results

The diagnostic performance of plasma aldosterone concentration (PAC) post-CCT was greater than that of ARR post-CCT and ARR pre-CCT in PA (area under the curve=0.956, 0.797, and 0.748, respectively; P=0.001). A cut-off value of 13 ng/dL showed the highest diagnostic odds ratio considering PAC post-CCT at 60 and 90 minutes. A PAC post-CCT of 19 ng/dL had a specificity of 100%, which can be used as a cut-off value for the confirmative test. Determining the diagnostic performance of PAC post-CCT at 90 minutes was sufficient for PA diagnosis. Subjects with PAC post-CCT at 90 minutes <13 ng/dL are less likely to have PA, and those with PAC post-CCT at 90 minutes ≥13 but <19 ng/dL should undergo secondary confirmatory tests.

Conclusion

The CCT test may be a reliable post-screening test to avoid the hospitalization in the setting of falsely elevated ARR screening tests.

Citations

Citations to this article as recorded by  
  • Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study
    Rui Zhu, Tungalagtamir Shagjaa, Giacomo Rossitto, Brasilina Caroccia, Teresa Maria Seccia, Dario Gregori, Gian Paolo Rossi
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(2): 496.     CrossRef
  • Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling
    Xinyu Liu, Chao Guo, Jin Bian, Sufang Hao, Ying Lou, Huimin Zhang, Xianliang Zhou, Jun Cai, Wenjun Ma
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis
    Alexander A. Leung, Christopher J. Symonds, Gregory L. Hundemer, Paul E. Ronksley, Diane L. Lorenzetti, Janice L. Pasieka, Adrian Harvey, Gregory A. Kline
    Hypertension.2022; 79(8): 1835.     CrossRef
  • Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism
    Junji Kawashima, Eiichi Araki, Mitsuhide Naruse, Isao Kurihara, Katsutoshi Takahashi, Kouichi Tamura, Hiroki Kobayashi, Shintaro Okamura, Shozo Miyauchi, Koichi Yamamoto, Shoichiro Izawa, Tomoko Suzuki, Akiyo Tanabe
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(5): e1990.     CrossRef
  • The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism
    Aya Saiki, Daisuke Tamada, Reiko Hayashi, Kosuke Mukai, Tetsuhiro Kitamura, Mitsuyoshi Takahara, Michio Otsuki, Iichiro Shimomura
    Hypertension Research.2019; 42(8): 1186.     CrossRef
  • The characteristics of captopril challenge test–positive patients using various criteria
    Satoshi Kidoguchi, Naoki Sugano, Naomi Hayashi-Ishikawa, Norihiko Morisawa, Goro Tokudome, Takashi Yokoo
    Journal of the Renin-Angiotensin-Aldosterone System.2019; 20(3): 147032031987089.     CrossRef
  • Confirmatory tests for the diagnosis of primary aldosteronism: A systematic review and meta‐analysis
    Sicen Wu, Jun Yang, Jinbo Hu, Ying Song, Wenwen He, Shumin Yang, Rong Luo, Qifu Li
    Clinical Endocrinology.2019; 90(5): 641.     CrossRef
  • The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
    Ke-ying Zhu, Yan Zhang, Wen-jing Zhang, Hong-yun Li, Wen-huan Feng, Da-long Zhu, Ping Li
    BMC Endocrine Disorders.2019;[Epub]     CrossRef
  • Confirmatory Tests for the Diagnosis of Primary Aldosteronism
    Ying Song, Shumin Yang, Wenwen He, Jinbo Hu, Qingfeng Cheng, Yue Wang, Ting Luo, Linqiang Ma, Qianna Zhen, Suhua Zhang, Mei Mei, Zhihong Wang, Hua Qing, Dennis Bruemmer, Bin Peng, Qifu Li
    Hypertension.2018; 71(1): 118.     CrossRef
  • Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism
    Xiao Meng, Yanyan Li, Xiaohao Wang, Jianwei Li, Yuping Liu, Yerong Yu
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(3): 853.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice
    A Ram Hong, Jung Hee Kim, Kyeong Seon Park, Kyong Young Kim, Ji Hyun Lee, Sung Hye Kong, Seo Young Lee, Chan Soo Shin, Sang Wan Kim, Seong Yeon Kim
    European Journal of Endocrinology.2017; 177(6): 475.     CrossRef
  • Agkihpin, a novel SVTLE from Gloydius halys Pallas, promotes platelet aggregation in vitro and inhibits thrombus formation in vivo in murine models of thrombosis
    Huiqiong Xie, Miao Huang, Qiping Hu, Kejian Sun, Huayu Wu, Wei Shu, Xiaolong Li, Ling Fang
    Toxicon.2016; 122: 78.     CrossRef
Close layer
Clinical Study
Radiographic Characteristics of Adrenal Masses in Oncologic Patients
Ji Hyun Lee, Eun Ky Kim, A Ram Hong, Eun Roh, Jae Hyun Bae, Jung Hee Kim, Chan Soo Shin, Seong Yeon Kim, Sang Wan Kim
Endocrinol Metab. 2016;31(1):147-152.   Published online March 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.1.147
  • 4,450 View
  • 36 Download
  • 9 Web of Science
  • 8 Crossref
AbstractAbstract PDFPubReader   
Background

We aimed to assess the usefulness of pre-contrast Hounsfield unit (HU) and mass size on computed tomography to differentiate adrenal mass found incidentally in oncologic patients.

Methods

From 2000 to 2012, 131 oncologic patients with adrenal incidentaloma were reviewed retrospectively. Receiver operating characteristic (ROC) curves were applied to determine the optimal cut-off value of the mean HU and size for detecting adrenal metastasis.

Results

The median age was 18 years, and 80 patients were male. The initial mass size was 18 mm, and 71 (54.2%) of these were on the left side. A bilateral adrenal mass was found in 11 patients (8.4%). Biochemically functional masses were observed in 9.2% of patients. Thirty-six out of 119 patients with nonfunctional masses underwent adrenalectomy, which revealed metastasis in 13. The primary cancers were lung cancer (n=4), renal cell carcinoma (n=2), lymphoma (n=2), hepatocellular carcinoma (n=2), breast cancer (n=1), and others (n=2). The area under the curve for the size and HU for clinically suspicious metastasis were 0.839 (95% confidence interval [CI], 0.761 to 0.900; P<0.001) and 0.959 (95% CI, 0.898 to 0.988; P<0.001), respectively. The cut-off value to distinguish between metastasis and benign masses were 22 mm for size and 20 for HU.

Conclusion

ROC curve results suggest that pre-contrast HU >20 can be used as a diagnostic reference to suggest metastasis in oncologic patients with adrenal masses.

Citations

Citations to this article as recorded by  
  • Risk of malignancy in adrenal tumors in patients with a history of cancer
    Radosław Samsel, Karolina Nowak, Lucyna Papierska, Edyta Karpeta, Katarzyna Roszkowska-Purska, Wacław Smiertka, Tomasz Ostrowski, Eryk Chrapowicki, Alan Grabowski, Dorota Leszczyńska, Andrzej Cichocki
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Adrenal Tumors Found During Staging and Surveillance for Colorectal Cancer: Benign Incidentalomas or Metastatic Disease?
    Mio Yanagisawa, Dania G. Malik, Thomas W. Loehfelm, Ghaneh Fananapazir, Michael T. Corwin, Michael J. Campbell
    World Journal of Surgery.2020; 44(7): 2282.     CrossRef
  • Predictive factors for adrenal metastasis in extra‐adrenal malignancy patients with solitary adrenal mass
    Kyeong‐Hyeon Byeon, Yun‐Sok Ha, Seock‐Hwan Choi, Bum Soo Kim, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Jun Nyung Lee, Tae‐Hwan Kim
    Journal of Surgical Oncology.2018; 118(8): 1271.     CrossRef
  • Combining Washout and Noncontrast Data From Adrenal Protocol CT
    Chaan S. Ng, Emre Altinmakas, Wei Wei, Payel Ghosh, Xiao Li, Elizabeth G. Grubbs, Nancy A. Perrier, Victor G. Prieto, Jeffrey E. Lee, Brian P. Hobbs
    Academic Radiology.2018; 25(7): 861.     CrossRef
  • Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors
    Youichi Ohno, Masakatsu Sone, Daisuke Taura, Toshinari Yamasaki, Katsutoshi Kojima, Kyoko Honda-Kohmo, Yorihide Fukuda, Koji Matsuo, Toshihito Fujii, Akihiro Yasoda, Osamu Ogawa, Nobuya Inagaki
    Hypertension Research.2018; 41(3): 165.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • The Diverse Clinical Presentations of Adrenal Lymphoma
    Awais Masood, Anna Tumyan, Daniel R. Nussenzveig, Dara N. Wakefield, Diana Barb, Hans K. Ghayee, Naim M. Maalouf
    AACE Clinical Case Reports.2017; 3(4): 307.     CrossRef
  • Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice
    A Ram Hong, Jung Hee Kim, Kyeong Seon Park, Kyong Young Kim, Ji Hyun Lee, Sung Hye Kong, Seo Young Lee, Chan Soo Shin, Sang Wan Kim, Seong Yeon Kim
    European Journal of Endocrinology.2017; 177(6): 475.     CrossRef
Close layer
Adrenal gland
Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease
A Ram Hong, Jung Hee Kim, Eun Shil Hong, I Kyeong Kim, Kyeong Seon Park, Chang Ho Ahn, Sang Wan Kim, Chan Soo Shin, Seong Yeon Kim
Endocrinol Metab. 2015;30(3):297-304.   Published online August 4, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.297
  • 4,853 View
  • 68 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   
Background

Measurement of the plasma adrenocorticotropic hormone (ACTH) level has been recommended as the first diagnostic test for differentiating between ACTH-independent Cushing syndrome (CS) and ACTH-dependent CS. When plasma ACTH values are inconclusive, a differential diagnosis of CS can be made based upon measurement of the serum dehydroepiandrosterone sulfate (DHEA-S) level and results of the high-dose dexamethasone suppression test (HDST). The aim of this study was to assess the utility of plasma ACTH to differentiate adrenal CS from Cushing' disease (CD) and compare it with that of the HDST results and serum DHEA-S level.

Methods

We performed a retrospective, multicenter study from January 2000 to May 2012 involving 92 patients with endogenous CS. The levels of plasma ACTH, serum cortisol, 24-hour urine free cortisol (UFC) after the HDST, and serum DHEA-S were measured.

Results

Fifty-seven patients had adrenal CS and 35 patients had CD. The area under the curve of plasma ACTH, serum DHEA-S, percentage suppression of serum cortisol, and UFC after HDST were 0.954, 0.841, 0.950, and 0.997, respectively (all P<0.001). The cut-off values for plasma ACTH, percentage suppression of serum cortisol, and UFC after HDST were 5.3 pmol/L, 33.3%, and 61.6%, respectively. The sensitivity and specificity of plasma ACTH measurement were 84.2% and 94.3%, those of serum cortisol were 95.8% and 90.6%, and those of UFC after the HDST were 97.9% and 96.7%, respectively.

Conclusion

Significant overlap in plasma ACTH levels was seen between patients with adrenal CS and those with CD. The HDST may be useful in differentiating between these forms of the disease, especially when the plasma ACTH level alone is not conclusive.

Citations

Citations to this article as recorded by  
  • Development of diagnostic algorithm for Cushing’s syndrome: a tertiary centre experience
    A. Efthymiadis, H. Loo, B. Shine, T. James, B. Keevil, J. W. Tomlinson, A. Pal, R. Pofi
    Journal of Endocrinological Investigation.2024;[Epub]     CrossRef
  • Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)
    I. E. Chazova, N. M. Chikhladze, N. V. Blinova, Zh. E. Belaya, N. M. Danilov, E. M. Elfimova, A. Yu. Litvin, L. Ya. Rozhinskaya, N. Yu. Sviridenko, M. Yu. Shvetsov, V. A. Azizov, E. A. Grigorenko, N. P. Mit’kovskaja, I. I. Mustafaev, A. G. Polupanov, A. S
    Eurasian heart journal.2023; (1): 6.     CrossRef
  • Diagnosis and Management of Pituitary Adenomas
    Nicholas A. Tritos, Karen K. Miller
    JAMA.2023; 329(16): 1386.     CrossRef
  • Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
    Chang Gao, Li Ding, Xiaona Zhang, Menghua Yuan, Shaofang Tang, Wei Li, Yuanyuan Ye, Ming Liu, Qing He
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The Importance of DHEA-S Levels in Cushing’s Syndrome; Is There a Cut-off Value in the Differential Diagnosis?
    Sema Ciftci, Ozlem Soyluk, Alev Selek, Selvinaz Erol, Zeliha Hekimsoy, Ayse Esen, Huseyin Dursun, Serdar Sahin, Gonca Oruk, Meral Mert, Huseyin Soylu, Banu Sarer Yurekli, Melek Eda Ertorer, Tulay Omma, Mehtap Evran, Mine Adas, Seher Tanrikulu, Kadriye Ayd
    Hormone and Metabolic Research.2022; 54(04): 232.     CrossRef
  • Epidemiology and Comorbidity of Adrenal Cushing Syndrome: A Nationwide Cohort Study
    Chang Ho Ahn, Jung Hee Kim, Man Young Park, Sang Wan Kim
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1362.     CrossRef
  • Metabolic changes in serum steroids for diagnosing and subtyping Cushing’s syndrome
    Chang Ho Ahn, Chaelin Lee, Jaeyoon Shim, Sung Hye Kong, Su-jin Kim, Yong Hwy Kim, Kyu Eun Lee, Chan Soo Shin, Jung Hee Kim, Man Ho Choi
    The Journal of Steroid Biochemistry and Molecular Biology.2021; 210: 105856.     CrossRef
  • Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients
    Insoon Jang, Su-jin Kim, Ra-Young Song, Kwangsoo Kim, Seongmin Choi, Jang-Seok Lee, Min-Kyeong Gwon, Moon Woo Seong, Kyu Eun Lee, Jung Hee Kim
    Endocrinology and Metabolism.2021; 36(6): 1287.     CrossRef
  • Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
    Daham Kim, Cheol Ryong Ku, Se Hee Park, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Eun Jig Lee
    World Neurosurgery.2018; 115: e464.     CrossRef
  • Cushing's syndrome: a practical approach to diagnosis and differential diagnoses
    Joseph M Pappachan, Christian Hariman, Mahamood Edavalath, Julian Waldron, Fahmy W Hanna
    Journal of Clinical Pathology.2017; 70(4): 350.     CrossRef
Close layer
Adrenal gland
Adrenocorticotropic Hormone-Independent Cushing Syndrome with Bilateral Cortisol-Secreting Adenomas
Eu Jeong Ku, A Ram Hong, Ye An Kim, Jae Hyun Bae, Mee Soo Chang, Sang Wan Kim
Endocrinol Metab. 2013;28(2):133-137.   Published online June 18, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.2.133
  • 3,994 View
  • 44 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   

A 48-year-old woman was incidentally found to have bilateral adrenal masses, 2.8 cm in diameter on the right, and 2.3 cm and 1.7 cm in diameter on the left, by abdominal computed tomography. The patient had a medical history of hypertension, which was not being controlled by carvedilol, at a dose of 25 mg daily. She presented with signs and symptoms that suggested Cushing Syndrome. We diagnosed adrenocorticotropic hormone (ACTH)-independent Cushing Syndrome based on the results of basal and dynamic hormone tests. Adrenal vein sampling (AVS) was performed to localize a functioning adrenal cortical mass. AVS results were consistent with hypersecretion of cortisol from both adrenal glands, with a cortisol lateralization ratio of 1.1. Upon bilateral laparoscopic adrenalectomy, bilateral ACTH-independent adrenal adenomas were found. The patient's signs and symptoms of Cushing Syndrome improved after surgery just as the blood pressure was normalized. After surgery, the patient was started on glucocorticoid and mineralocorticoid replacement therapy.

Citations

Citations to this article as recorded by  
  • Recent Advances in the Clinical Application of Adrenal Vein Sampling
    Shan Zhong, Tianyue Zhang, Minzhi He, Hanxiao Yu, Zhenjie Liu, Zhongyi Li, Xiaoxiao Song, Xiaohong Xu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients
    German Rubinstein, Andrea Osswald, Leah Theresa Braun, Frederick Vogel, Matthias Kroiss, Stefan Pilz, Sinan Deniz, Laura Aigner, Thomas Knösel, Jérôme Bertherat, Lucas Bouys, Roland Ladurner, Anna Riester, Martin Bidlingmaier, Felix Beuschlein, Martin Rei
    Endocrine.2022; 76(2): 434.     CrossRef
  • Concomitant coexistence of ACTH‐dependent and independent Cushing syndrome
    Ach Taieb, Saad Ghada, Gorchène Asma, Ben Abdelkrim Asma, Kacem Maha, Ach Koussay
    Clinical Case Reports.2022;[Epub]     CrossRef
  • The Value of Adrenal Androgens for Correcting Cortisol Lateralization in Adrenal Venous Sampling in Patients with Normal Cortisol Secretion
    Wenjing Zhang, Keying Zhu, Hongyun Li, Yan Zhang, Dalong Zhu, Xuebin Zhang, Ping Li
    International Journal of Endocrinology.2019; 2019: 1.     CrossRef
  • Adrenal venous sampling in patients with ACTH-independent hypercortisolism
    Eleni Papakokkinou, Hugo Jakobsson, Augustinas Sakinis, Andreas Muth, Bo Wängberg, Olof Ehn, Gudmundur Johannsson, Oskar Ragnarsson
    Endocrine.2019; 66(2): 338.     CrossRef
  • ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures
    Jia Wei, Sheyu Li, Qilin Liu, Yuchun Zhu, Nianwei Wu, Ying Tang, Qianrui Li, Kaiyun Ren, Qianying Zhang, Yerong Yu, Zhenmei An, Jing Chen, Jianwei Li
    BMC Endocrine Disorders.2018;[Epub]     CrossRef
  • A case of adrenal Cushing’s syndrome with bilateral adrenal masses
    Ya-Wun Guo, Chii-Min Hwu, Justin Ging-Shing Won, Chia-Huei Chu, Liang-Yu Lin
    Endocrinology, Diabetes & Metabolism Case Reports.2016;[Epub]     CrossRef
  • Bilateral Adrenocortical Masses Producing Aldosterone and Cortisol Independently
    Seung-Eun Lee, Jae Hyeon Kim, You-Bin Lee, Hyeri Seok, In Seub Shin, Yeong Hee Eun, Jung-Han Kim, Young Lyun Oh
    Endocrinology and Metabolism.2015; 30(4): 607.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • A Case of Bilateral ACTH-independent Adrenal Adenomas with Cushing's Syndrome Treated by Ipsilateral Total and Contralateral Partial Laparoscopic Adrenalectomy
    Seung Ah Park, Dong min Jung, Soon young Kim, Nan Young Choi, Tae-jun Kim, Yong kyun Kim, Seong kyun Na, Chul Sik Kim, Seong Jin Lee, Sung-Hee Ihm, Jun Goo Kang
    The Korean Journal of Obesity.2013; 22(4): 254.     CrossRef
Close layer
A Case Report of Bilateral Adrenocortical Carcinoma Complicated by Adrenal Insufficiency.
Min Joo Kim, Jung Hee Kim, Tae Young Kim, Sang Wan Kim
Endocrinol Metab. 2011;26(3):243-247.   Published online September 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.3.243
  • 2,019 View
  • 29 Download
  • 2 Crossref
AbstractAbstract PDF
Adrenocortical carcinoma is often functional and presents with signs and symptoms of adrenal steroid hormone excess. Adrenal insufficiency secondary to bilateral adrenocortical carcinoma is a particularly rare complication. We recently encountered a case of bilateral adrenocortical carcinoma complicated by adrenal insufficiency. A 52-year-old male was transferred to this hospital complaining of general weakness and weight loss. A bilateral adrenal mass was detected on abdomen CT. Plasma cortisol and aldosterone failed to rise during the rapid ACTH stimulation test. The CT-guided adrenal biopsy revealed findings consistent with adrenocortical carcinoma. Left hemiparesis was developed and brain metastasis was detected via brain MRI. Despite the application of gamma knife surgery and chemotherapy, the disease progressed and the patient died.

Citations

Citations to this article as recorded by  
  • Bilateral Adrenocortical Carcinoma Presenting as Acute Adrenal Insufficiency
    Anshita Aggarwal, Aprajita Verma, Aparajita Roy, Bindu Kulshreshtha
    European Endocrinology.2020; 16(2): 172.     CrossRef
  • A Case of Bilateral ACTH-independent Adrenal Adenomas with Cushing's Syndrome Treated by Ipsilateral Total and Contralateral Partial Laparoscopic Adrenalectomy
    Seung Ah Park, Dong min Jung, Soon young Kim, Nan Young Choi, Tae-jun Kim, Yong kyun Kim, Seong kyun Na, Chul Sik Kim, Seong Jin Lee, Sung-Hee Ihm, Jun Goo Kang
    The Korean Journal of Obesity.2013; 22(4): 254.     CrossRef
Close layer
Androgen Receptor Gene CAG Repeat Polymorphism and Effect of Testosterone Therapy in Hypogonadal Men in Korea.
Min Joo Kim, Jin Taek Kim, Sun Wook Cho, Sang Wan Kim, Chan Soo Shin, Kyong Soo Park, Seong Yeon Kim
Endocrinol Metab. 2011;26(3):225-231.   Published online September 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.3.225
  • 2,047 View
  • 25 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
As the number of CAG repeats in the androgen receptor (AR) gene increases, transcriptional activities decrease and the effects of testosterone decline. In this study, we evaluated the importance of the CAG repeat polymorphism in regard to the effect/safety of testosterone therapy in hypogonadal Korean men. METHODS: The number of CAG repeats was determined in 42 hypogonadal men who underwent testosterone therapy for more than 24 months between December 1999 and August 2007. Body mass index, lean body mass, body fat, bone mineral density, type I collagen N-telopeptide (NTx), osteocalcin, lipid profile, hematocrit and PSA levels prior to and after 24 months of testosterone therapy were identified in our medical record review. RESULTS: Twenty-four months of testosterone therapy increased lean body mass, hematocrit, and PSA levels and reduced body fat, NTx, and HDL cholesterol levels. The mean number of CAG repeats in the AR gene was 23 +/- 3 (range, 15-29) in hypogonadal Korean men. The number of CAG repeats was not found to be associated with changes in lean body mass, body fat, NTx, HDL cholesterol, hematocrit, or PSA levels during testosterone therapy. CONCLUSIONS: No association between the number of CAG repeats in the AR gene and the effect/safety of testosterone therapy was detected in hypogonadal Korean men.

Citations

Citations to this article as recorded by  
  • Androgen Receptor CAG Repeat Length as a Risk Factor of Late-Onset Hypogonadism in a Korean Male Population
    Jong Wook Kim, Young Dae Bae, Sun Tae Ahn, Jin Wook Kim, Je Jong Kim, Du Geon Moon
    Sexual Medicine.2018; 6(3): 203.     CrossRef
  • Positive Correlation between Androgen Receptor CAG Repeat Length and Metabolic Syndrome in a Korean Male Population
    Jong Wook Kim, Young Dae Bae, Sun Tae Ahn, Jin Wook Kim, Je Jong Kim, Du Geon Moon
    The World Journal of Men's Health.2018; 36(1): 73.     CrossRef
  • Genome-Based Approaches in Endocrinology and Metabolism: From Clinical and Research Aspects
    Sihoon Lee
    Endocrinology and Metabolism.2011; 26(3): 208.     CrossRef
Close layer
No Significance of the Free Cortisol Index Compared to Total Cortisol in Critically Ill Patients.
Kyung Won Kim, Sang Wan Kim, Hee Joung Kim, Chan Soo Shin, Sung Jae Park, Gil Joon Suh, Seong Yeon Kim
Endocrinol Metab. 2011;26(2):120-125.   Published online June 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.2.120
  • 1,893 View
  • 21 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Some patients exhibit an inadequate response of cortisol to stressful conditions; this state is known as critical illness-related corticosteroid insufficiency. These patients have low serum binding protein concentrations, thereby suggesting that total serum cortisol may not be reflective of circulating cortisol activity. As the free cortisol index (FCI = total cortisol/corticosteroid-binding globulin) has been correlated with serum free cortisol, we measured FCI in Korean patients for the first time. In this study, we attempted to determine whether FCI was superior to total cortisol in predicting 30-day mortality. METHODS: We recruited 65 critically ill patients with relatively high Acute Physiology, Age and Chronic Health Evaluation (APACHE III) scores. Fourteen patients with pituitary disease but normal pituitary function were recruited from outpatient clinics. Total cortisol and corticosteroid-binding globulin were measured in patients and controls during the short Synacthen test. RESULTS: The basal cortisol level and basal FCI level were higher in patients (n = 65) than in healthy controls (P < 0.001, respectively). We found that total cortisol was strongly correlated with FCI (P < 0.001) in critically ill patients; however, neither total cortisol nor FCI were associated with 30-day mortality among patients. Only severe clinical criteria (such as APACHE-III scores and low albumin) were associated with 30-day mortality. CONCLUSION: Our results do not suggest that FCI is more accurate than total cortisol in predicting clinical outcomes in critically ill patients.

Citations

Citations to this article as recorded by  
  • No Significance of the Free Cortisol Index Compared to Total Cortisol in Critically Ill Patients
    Doo-Man Kim
    Endocrinology and Metabolism.2011; 26(2): 118.     CrossRef
Close layer
Six Cases of Congenital Adrenal Hyperplasia That Were Due to 17alpha-hydroxylase/17,20-lyase Deficiency.
Dong Hoon Shin, Sung Hoon Yu, Young Min Choi, Jung Gu Kim, Sang Wan Kim, Chan Soo Shin, Kyong Soo Park, Seong Yeon Kim
J Korean Endocr Soc. 2009;24(2):109-115.   Published online June 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.2.109
  • 1,972 View
  • 29 Download
  • 2 Crossref
AbstractAbstract PDF
17alpha-hydroxylase/17,20-lyase deficiency is a rare phenotype of congenital adrenal hyperplasia (CAH), and this is characterized by hyporeninemic hypertension, primary amenorrhea and abnormality of the secondary sexual characteristics (pseudohermaphroditism in men). This type of CAH is usually misdiagnosed at first as mineralocorticoid induced hypertension with primary aldosteronism, but primary amenorrhea with deficient sex hormone is a clue for making the correct diagnosis. The authors experienced 6 cases of 17alpha-hydroxylase/17,20-lyase deficiency in patients who ranged from 15 to 42 years of age. 4 cases were diagnosed according to the investigation of their mineralocorticoid-induced hypertension and 2 cases their primary amenorrhea and sexual infantilism. All of them had hypokalemia, hyporeninemic hypertension and an atrophied uterus and ovaries. In the genotypic male (46 XY), the testicles were atrophied in the abdominal cavity. The levels of cortisol, estrogen and dehydroepiandrosterone sulfate (DHEAS) were low, but the levels of progesterone and 11-deoxycorticosterone were high. Therefore, the diagnosis of 17alpha-hydroxylase/17,20-lyase deficiency should be considered in female patients who present with both sexual infantilism and mineralocorticoid hypertension. We report on these cases with a brief review of the literature.

Citations

Citations to this article as recorded by  
  • Functional Identification of Compound Heterozygous Mutations in the CYP17A1 Gene Resulting in Combined 17α-Hydroxylase/17,20-Lyase Deficiency
    Eun Yeong Mo, Ji-young Lee, Su Yeon Kim, Min Ji Kim, Eun Sook Kim, Seungok Lee, Je Ho Han, Sung-dae Moon
    Endocrinology and Metabolism.2018; 33(3): 413.     CrossRef
  • 17α-hydroxylase Deficiency Mimicking Hyperaldosteronism by Aldosterone-producing Adrenal Adenoma
    Yun Kyung Cho, Hyeseon Oh, Sun-myoung Kang, Sujong An, Jin-Young Huh, Ji-Hyang Lee, Woo Je Lee
    The Korean Journal of Medicine.2016; 91(2): 191.     CrossRef
Close layer
Discrepancy between the Growth Hormone and Insulin-like Growth Factor-I Concentrations in Patients with Acromegaly.
Ji Won Yoon, Mi Yeon Kang, Hwa Young Ahn, Jee Hyun An, Sang Wan Kim, Chan Soo Shin, Kyong Soo Park, Hak Chul Jang, Bo Youn Cho, Hong Kyu Lee, Seong Yeon Kim
J Korean Endocr Soc. 2008;23(6):395-403.   Published online December 1, 2008
DOI: https://doi.org/10.3803/jkes.2008.23.6.395
  • 1,875 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
This study was performed to evaluate the frequency and clinical characteristics of patients with active acromegaly and who show discordance of the growth hormone (GH) level and the insulin-like growth factor-I (IGF-I) level. METHODS: We reviewed the medical records of the patients who were diagnosed with acromegaly between 01/01/1995 and 6/30/2007 at Seoul National University Hospital. We selected only the patients whose basal GH and IGF-I levels were available. We investigated the pre- and post-operative clinical characteristics, as well as the blood concentrations of GH and IGF-I. The concordance rate between the two hormones was examined. The patients were considered to have active disease on the basis of their IGF-I levels above the normal range, after adjustment for age and gender, and their mean basal GH value was > or = 2.5 microgram/L. The hormone levels and the clinical parameters were compared between the hormone concordant and discordant groups. RESULTS: We reviewed the preoperative records of 103 acromegalic patients, and these patients met the above-mentioned criteria. 53 postoperative patients who were not cured by operation were monitored without them receiving radiation or medical therapy. Both the basal GH and IGF-I levels were above normal in 103 patients preoperatively, and the discordant rate was 0% (0/103 cases). Postoperatively, the discordant rate between the two hormones was increased to 30.2% (16/53 cases). Age, gender, body mass index and tumor size were insignificantly different between the concordant and discordant groups. However, postoperative residual tumors were less frequently observed in the discordant group (P = 0.006). CONCLUSION: For the patients with acromegaly, unlike the 0% discordance preoperatively, 30.2% of patients showed a discrepancy between their GH and IGF-I levels postoperatively. The patients who had hormonal discrepancy were less likely to have residual tumors after operation. Considering the frequency of this hormonal discrepancy, both hormone levels should be measured to evaluate the disease activity after treatment. Further, oral glucose tolerance testing should be performed and especially for the patients with an increased GH level, but who have a normal IGF-I concentration.
Close layer
Characteristics and Natural Course of Pituitary Incidentaloma in Korea.
You Jin Lee, Sun Wook Cho, Sang Wan Kim, Chan Soo Shin, Kyong Soo Park, Bo Youn Cho, Hong Kyu Lee, Seong Yeon Kim
J Korean Endocr Soc. 2008;23(2):111-116.   Published online April 1, 2008
DOI: https://doi.org/10.3803/jkes.2008.23.2.111
  • 1,644 View
  • 19 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
A pituitary incidentaloma is a pituitary mass discovered incidentally by computed tomography (CT) or magnetic resonance (MRI) of the brain performed for evaluation of an unrelated disease, and when the patient did not show neurological or endocrine signs and symptoms. Despite of increasing incidence, only a few studies have reported on characteristics, natural history, treatment, or follow-up strategy. Moreover no epidemiologic data exist on pituitary incidentaloma in Korean. METHODS: We retrospectively enrolled subjects diagnosed as pituitary incidentaloma in Seoul National University Hospital from January 1992 to August 2006. We reviewed baseline demographic findings and the results of basal hormone tests, visual field test, and MRI (or CT) at baseline and during follow-up. RESULTS: Among 1310 patients with pituitary adenoma, 161 subjects were diagnosed with incidentaloma. The subject age at diagnosis was 49.7 +/- 15.5 years, with 84 males. Macroadenoma was more frequent (n = 110, 68.3%). with microadenomas and Rathke's cleft cysts found in 21 and 30 cases, respectively. The mean diameter of the tumor was 1.75 cm. Functional incidentalomas such as prolactinoma or acromegaly were found in 31 cases (19.3%) although there were no symptoms or visual field defects. Of 61 incidentaloma patients who did not undergo surgery or other treatment over one year, only 3 patient showed an increase in tumor size during the mean 38.0 +/- 24.9 months follow-up. CONCLUSION: Pituitary incidentaloma generally showed a benign course despite the high prevalence of macroadenoma (68.3%). However, as about 20% of the patients had functioning tumors, pituitary hormonal evaluation at diagnosis is mandatory. Furthermore, as we experienced 3 cases with increased tumor size during follow up, including a case of pituitary microadenoma, long-term careful follow-up of pituitary incidentaloma seems necessary. A long-term, prospective study with more patients would reveal the characteristics and the natural history of pituitary incidentalomas in Korea.

Citations

Citations to this article as recorded by  
  • Sellar Masses: An Epidemiological Study
    Khaled Al-Dahmani, Syed Mohammad, Fatima Imran, Chris Theriault, Steve Doucette, Deborah Zwicker, Churn-Ern Yip, David B. Clarke, Syed Ali Imran
    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2016; 43(2): 291.     CrossRef
  • Optimal Surgical Approaches for Rathke Cleft Cyst With Consideration of Endocrine Function
    Jeong Kyung Park, Eun Jig Lee, Sun Ho Kim
    Operative Neurosurgery.2012; 70: ons250.     CrossRef
  • Clinical Characteristics of 16 Patients with Pituitary Tumor Incidentally Detected by18F-Fluorodeoxyglucose PET-CT (18F-FDG PET-CT)
    Hyung Jin Kim, Gi Jeong Cheon, A Ra Cho, Chang Hoon Lee, Sang Min Youn, Se jin Ahn, Sang Eon Jang, Jung Min Kim, Yun Yong Lee, Ka Hee Yi
    Endocrinology and Metabolism.2010; 25(4): 321.     CrossRef
Close layer
The Clinical Implication and Problems of Adrenal Vein Sampling in Patients with Primary Aldosteronism.
Jie Seon Lee, Mi Yeon Kang, Sang Wan Kim, Chan Soo Shin, Seong Yeon Kim, Jin Wook Chung
J Korean Endocr Soc. 2007;22(6):428-435.   Published online December 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.6.428
  • 2,208 View
  • 21 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Recently, the significance of primary aldosteronism is being recognized due to an increase in its incidence and its complications. However, it is difficult to differentiate primary aldosteronism based on radiological studies as the size of an aldosterone producing adenoma (APA) is small, and nonfunctioning adrenal incidentalomas are common. Adrenal vein sampling (AVS) has been considered as the gold standard for differentiating an aldosterone producing adenoma (APA) from bilateral idiopathic adrenal hyperplasia (BAH). The clinical implications and problems associated with AVS have not yet been reported in Korea. METHOD: Clinical data of 28 patients with primary aldosteronism who had undergone AVS in a hospital from 1995 to 2006 were retrospectively analyzed. RESULT: The study group comprised 13 males (46.4%) and 15 females (53.5%), with a mean age of 44.5 +/- 11.9 years. Clinical data indicated that 19 patients (67.9%) had APA and nine patients (32.1%) had BAH. AVS data demonstrated that 11 patients had APA and five patients had BAH. Two patients were not diagnosed despite successful AVS. AVS was not successful in 10 patients (37.5%); AV catheterization failed in two patients, was not selective in seven patients on the right side, and was not selective in one patient on the left side. CONCLUSION: AVS was helpful in primary aldosteronism patients with inconclusive CT and MRI findings. Selectivity of AVS should be appropriately assessed because of the technical problem of selective catheterization.

Citations

Citations to this article as recorded by  
  • Bilateral Adrenocortical Masses Producing Aldosterone and Cortisol Independently
    Seung-Eun Lee, Jae Hyeon Kim, You-Bin Lee, Hyeri Seok, In Seub Shin, Yeong Hee Eun, Jung-Han Kim, Young Lyun Oh
    Endocrinology and Metabolism.2015; 30(4): 607.     CrossRef
  • Primary Aldosteronism
    Sang Wan Kim
    Korean Journal of Medicine.2012; 82(4): 396.     CrossRef
Close layer
Clinical Characteristics for 132 Patients with Adrenal Incidentaloma.
Hyun Seung Jeong, Hee Joung Kim, Hae Sung Kim, Sang Wan Kim, Chan Soo Shin, Do Joon Park, Kyung Soo Park, Hak Cheol Jang, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2007;22(4):260-265.   Published online August 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.4.260
  • 2,096 View
  • 20 Download
  • 8 Crossref
AbstractAbstract PDF
BACKGROUND
Recently, the detection rate for adrenal incidentaloma in Korea has been on the increase. We describe here the clinical characteristics of these tumors and describe appropriate guidelines of diagnosis and treatment. METHODS: We analyzed age, sex, location, size, function, and the pathological findings for 132 patients with an adrenal mass by CT, USG, and MRI undertaken for health examinations or non-adrenal disease from January 2000 to March 2005. RESULTS: Adrenal masses were most commonly found in patients in their sixties (31%). 62.1% of the patients were men and 37.9% were women. For the location of the masses, 53% were found in the left gland, 43.2% were found in the right gland and 3.8% were found in both glands. Of all of the masses analyzed, 66% were 1 cm to 4 cm in size, and an adenoma-like appearance was the most common finding (69.7%) seen in images. All of the pheochromocytomas and carcinomas were above 4 cm in size. Patients with a functional mass were seen in 18 cases (13.6%) and pheochromocytomas were seen in 12 cases (67%). Three patients were found with cancer (2.3%), two cases (1.5%) of a primary carcinoma and one case of a metastasis (0.8%). CONCLUSION: The frequency and characteristics of benign nonfunctional, functional and malignant masses that were found in our hospital were similar to those presented in studies conducted outside of Korea. Therefore, it may be possible to apply previously established guidelines to domestic patients.

Citations

Citations to this article as recorded by  
  • Guidelines for the Management of Adrenal Incidentaloma: the Korean Endocrine Society, Committee of Clinical Practice Guidelines
    Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang-Wan Kim, Soo-Kyung Kim, Hae-Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung-Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
    The Korean Journal of Medicine.2017; 92(1): 4.     CrossRef
  • Clinical Guidelines for the Management of Adrenal Incidentaloma
    Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang Wan Kim, Soo-Kyung Kim, Hae Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
    Endocrinology and Metabolism.2017; 32(2): 200.     CrossRef
  • Clinical Characteristics for 348 Patients with Adrenal Incidentaloma
    Jongho Kim, Kwi Hyun Bae, Yeon Kyung Choi, Ji Yun Jeong, Keun Gyu Park, Jung Guk Kim, In Kyu Lee
    Endocrinology and Metabolism.2013; 28(1): 20.     CrossRef
  • Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas
    Yoon Young Cho, Sunghwan Suh, Ji Young Joung, Hyemin Jeong, Dongmo Je, Hongseok Yoo, Taek Kyu Park, Yong-Ki Min, Kwang-Won Kim, Jae Hyeon Kim
    The Korean Journal of Internal Medicine.2013; 28(5): 557.     CrossRef
  • Characterization of Incidentally Detected Adrenal Pheochromocytoma
    Soon Jib Yoo, Woohyeon Kim
    Endocrinology and Metabolism.2012; 27(2): 116.     CrossRef
  • Different diagnostic cut-off values of urinary fractionated metanephrines according to sex for the diagnosis of pheochromocytoma in Korean subjects
    Seo Young Sohn, Hyung Doo Park, Soo Youn Lee, Jung Han Kim, Byong Chang Jung, Hye Jeong Kim, Hye Won Jang, Kwang Won Kim, Moon Kyu Lee, Yong Ki Min, Jae Hyeon Kim
    Endocrine Journal.2012; 59(9): 831.     CrossRef
  • Characterization of Incidentally Detected Adrenal Pheochromocytoma
    Ye An Kim, Yul Hwangbo, Min Joo Kim, Hyung Jin Choi, Je Hyun Seo, Yenna Lee, Soo Heun Kwak, Eu Jeong Ku, Tae Jung Oh, Eun Roh, Jae Hyun Bae, Jung Hee Kim, Kyoung Soo Park, Seong Yeon Kim
    Endocrinology and Metabolism.2012; 27(2): 132.     CrossRef
  • The Evaluation and Follow-up of Adrenal Incidentaloma
    Sin Gon Kim, Dong Seop Choi
    Journal of Korean Endocrine Society.2007; 22(4): 257.     CrossRef
Close layer
A Case of Tumor-induced Osteomalacia with Elevated Fibroblast Growth Factor-23.
Hae Sung Kim, Hyun Seung Jung, Hee Jung Kim, Sung Yeon Kim, Sang Wan Kim, Chan Soo Shin, Chong Jai Kim, Seong Yeon Kim
J Korean Endocr Soc. 2007;22(2):142-148.   Published online April 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.2.142
  • 1,996 View
  • 22 Download
  • 12 Crossref
AbstractAbstract PDF
Tumor-induced osteomalacia (TIO), a paraneoplastic disease, is characterized by hypophosphatemia, and caused by renal phosphate wasting inappropriately, normal or decreased 1, 25(OH)2D3 production, and defective calcification of cartilage and bone. Because the removal of the responsible tumor normalizes phosphate metabolism, unidentified humoral phosphaturic factors (phosphatonin) are believed to be responsible for this syndrome. These factors include fibroblast growth factor (FGF)-23, secreted frizzled-related protein-4 and matrix extracellular phosphoglycoprotein. However, no case of TIO producing FGF-23 has been clearly reported in Korea. Herein, a case of TIO producing FGF-23 in a 45-year-old woman is reported. The patient presented with a large tumor on her buttock, with severe bone and muscle pain. A histological examination of the tumor revealed a mixed connective tissue tumor, consisting of deposition of calcified materials and surrounding primitive spindle cells, with prominent vascularity. Whether FGF-23 is a secreted factor, as well as its levels of expression in tumors were investigated. An immunohistochemical study showed the tumor cells to be FGF-23 positive. Furthermore, the levels of serum FGF-23 were extremely high and an RT-PCR analysis, using total RNA from the tumor, revealed the abundant expression of FGF-23 mRNA. After removal of the tumor, all the biochemical and hormonal abnormalities disappeared, with marked symptomatic improvement.

Citations

Citations to this article as recorded by  
  • Change in Patient's Ages Who Took an Adenoidectomy for 30 Years
    Eun Jung Lee, Ji Hoon Kim, Hye Jin Hwang, Min Ki Kim, Min Seok Kang, Kyung-Su Kim
    Journal of Rhinology.2017; 24(1): 8.     CrossRef
  • Dietary assessment according to frequency of food consumed away from home among children and adolescents: Based on the 2010~2012 Korea National Health and Nutrition Examination Survey
    Yong-Suk Kwon, Wan-Soo Hong, Seyoung Ju
    Journal of Nutrition and Health.2016; 49(6): 471.     CrossRef
  • Dyslipidemia in Children and Adolescents: When and How to Diagnose and Treat?
    Jung Min Yoon
    Pediatric Gastroenterology, Hepatology & Nutrition.2014; 17(2): 85.     CrossRef
  • Length and Volume of Morphologically Normal Kidneys in Korean Children: Ultrasound Measurement and Estimation Using Body Size
    Jun-Hwee Kim, Myung-Joon Kim, Sok Hwan Lim, Jieun Kim, Mi-Jung Lee
    Korean Journal of Radiology.2013; 14(4): 677.     CrossRef
  • Factors Influencing Obesity among Adolescent: Analysis of 2011 Korean Youth Risk Behavior Survey
    Young-Ju Jee, Young-Hae Kim
    The Korean Journal of Obesity.2013; 22(1): 39.     CrossRef
  • A Case of Nutritional Osteomalacia in Young Adult Male
    Choong-Kyun Noh, Min-Jeong Lee, Bu Kyung Kim, Yoon-Sok Chung
    Journal of Bone Metabolism.2013; 20(1): 51.     CrossRef
  • The Relationship between High Energy/Low Nutrient Food Consumption and Obesity among Korean Children and Adolescents
    Gyu Jin Heo, So-Young Nam, Soo-Kyung Lee, Sang-Jin Chung, Ji hyun Yoon
    Korean Journal of Community Nutrition.2012; 17(2): 226.     CrossRef
  • Changes in Prevalence of Obesity and Underweight among Korean Children and Adolescents: 1998-2008
    Ki Eun Kim, Shin Hye Kim, Sangshin Park, Young-Ho Khang, Mi Jung Park
    The Korean Journal of Obesity.2012; 21(4): 228.     CrossRef
  • A new age-based formula for estimating weight of Korean children
    Jungho Park, Young Ho Kwak, Do Kyun Kim, Jae Yun Jung, Jin Hee Lee, Hye Young Jang, Hahn Bom Kim, Ki Jeong Hong
    Resuscitation.2012; 83(9): 1129.     CrossRef
  • Lipid Profiles and Prevalence of Dyslipidemia in Korean Adolescents
    Shin Hye Kim, Byung Chul Ahn, Hyojee Joung, Mi Jung Park
    Endocrinology and Metabolism.2012; 27(3): 208.     CrossRef
  • Trends in obesity among Korean children using four different criteria
    Young-Ho Khang, Mi Jung Park
    International Journal of Pediatric Obesity.2011; 6(3-4): 206.     CrossRef
  • Usefulness of the Waist Circumference-to-Height Ratio in Screening for Obesity in Korean Children and Adolescents
    Joo Hyun Gil, Mi Na Lee, Hye Ah Lee, Hyesook Park, Jeong Wan Seo
    Korean Journal of Pediatric Gastroenterology and Nutrition.2010; 13(2): 180.     CrossRef
Close layer
Retrospective Observation of Long-Term Clinical Courses of Idiopathic Central Diabetes Insipidus in Adults.
Hee Joung Kim, Mi Yeon Kang, Kyung Won Kim, Hyun Seung Jeong, Hae Sung Kim, Sang Wan Kim, Seong Yeon Kim
J Korean Endocr Soc. 2006;21(6):482-489.   Published online December 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.6.482
  • 1,732 View
  • 17 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Idiopathic central diabetes insipidus (CDI) can be diagnosed when it occurs in the absence of a genetic or secondary cause known to be responsible for diabetes insipidus (DI). Some studies have reported that idiopathic CDI in adults shows a more benign clinical course than in children and young patients. However, the clinical characteristics and progress of this disorder have not been fully described. Therefore, we investigated the clinical courses of adult patients over the age of sixteen years with idiopathic central DI. METHODS: We reviewed the medical records of all patients who had documented cases of idiopathic CDI from 1989 to 2005, and studied clinical features, hormone data, and imaging studies at diagnosis and during at least 1-year of follow-up. RESULTS: There were 9 male (30.0%) and 21 female (70.0%) patients with a mean age of 39.3 years at diagnosis and a mean follow-up duration of 6.9 years. At diagnosis, deficits in anterior pituitary hormones were documented in 6 patients (20%), hyperprolactinemia in 4, and hypogonadism in 2. Two patients had an anterior pituitary hormone deficiency that was newly detected at a mean 3.4 years after the onset of DI. On initial MRI, the posterior pituitary was not hyperintense in 7 of the 30 patients (23.3%), but pituitary stalk thickening was observed in 15 (50.0%). After a mean follow-up of 6.9 years (range: 1 to 18), follow-up pituitary MRI showed improvement or no changes in patients with initial MRI findings of a pituitary abnormality, and no development of new lesions in 7 patients with a normal pituitary finding on initial MRI. CONCLUSION: Two of the 30 patients with idiopathic CDI developed an anterior pituitary hormone deficiency during follow-up, but no subject showed any aggravation on follow-up MRI. No patient showed a newly developed pituitary abnormality on follow-up MRI after a negative finding on the initial MRI.

Citations

Citations to this article as recorded by  
  • Central Diabetes Insipidus Surmised as from Post-obstructive Diuresis after Decompression Treatment for Neurogenic Bladder
    Kang-Woo Lee, Chul-Woo Yang, Dong-Jun Lim, Hyuk-Sang Kwon, Mi-Ja Kang, Eun-Sook Kim, Kun-Ho Yoon, Ho-Young Son, Bong-Yun Cha
    Journal of Korean Endocrine Society.2009; 24(2): 144.     CrossRef
Close layer
The Effects on Visceral Fat and Cardiovascular Risk Factors of Testosterone Replacement in Secondary Hypogonadal Men.
Eui Sil Hong, Sung Yeon Kim, Young Ju Choi, Sang Wan Kim, Chan Soo Shin, Kyong Soo Park, Hak Chul Jang, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2005;20(3):252-260.   Published online June 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.3.252
  • 1,862 View
  • 19 Download
  • 4 Crossref
AbstractAbstract PDF
BACKGROUND
Increased body fat, abdominal obesity and insulin resistance are important clinical features in hypogonadal men. Several studies have demonstrated that a low testosterone concentration in men is associated with coronary heart disease, visceral obesity and insulin resistance. In this study, the effects of testosterone replacement therapy on the abdominal visceral fat and cardiovascular risk factors in hypogonadal men were investigated. METHODS: We selected 26 men with secondary hypogonadism (mean serum testosterone+/-SD 0.39+/- 0.57ng/mL), who were then treated with testosterone for 12 months. We measured the body composition, including the abdominal visceral fat area by abdominal CT at the L4 level, both before and 12 months after treatment, and the lipid profile, fasting plasma insulin, HOMA-IR and the serum homocysteine, CRP and IL-6 before and 6, 12 months after treatment. RESULTS: With respect to the body composition, the lean body mass had significantly increased 12 months after treatment(P= 0.002), but there were no significant changes in the body fat mass and abdominal visceral fat area. There was a trend toward a decreased fasting plasma insulin and HOMA-IR, but this did not reach statistical significance. The total cholesterol had decreased significantly at 12 months(P=0.04) and the HDL cholesterol decreased significantly over the course of study(P=0.02). There were no significant changes in the serum homocysteine, CRP and IL-6 after treatment. CONCLUSIONS: After 12 months testosterone replacement therapy in the 26 men with hypogonadism, the lean body mass had increased significantly, but there was no significant change on the abdominal visceral fat during the treatment period. Testosterone replacement had deleterious effect on HDL cholesterol, but not significant effects on insulin resistance and the serum homocysteine, CRP and IL-6. These results suggest that testosterone replacement therapy may have a few adverse effects on cardiovascular diseases in hypogonadal men. However, it will be necessary to examine the long-term effects of testosterone replacement on the incidence of cardiovascular events as well as the cardiovascular risk factors in men with hypogonadism

Citations

Citations to this article as recorded by  
  • The Association of Level of Testosterone and Parameters of Obesity
    Chong Hwa Kim
    The Korean Journal of Obesity.2015; 24(1): 28.     CrossRef
  • The Relationship between Various Obesity Indices and Level of Male Hormone according to Different Age Groups
    Yoo-Jung Lee, Hyeon-Ju Kim, Mi-Hee Kong
    The Korean Journal of Obesity.2014; 23(4): 245.     CrossRef
  • Androgen Receptor Gene CAG Repeat Polymorphism and Effect of Testosterone Therapy in Hypogonadal Men in Korea
    Min Joo Kim, Jin Taek Kim, Sun Wook Cho, Sang Wan Kim, Chan Soo Shin, Kyong Soo Park, Seong Yeon Kim
    Endocrinology and Metabolism.2011; 26(3): 225.     CrossRef
  • Effects of Androgen on the Cardiovascular System in the Aging Male
    Jin Wook Kim, Je Jong Kim, Du Geon Moon
    Korean Journal of Andrology.2011; 29(1): 10.     CrossRef
Close layer
The Clinical Characteristics of Macroprolactinemia.
Young Ju Choi, Jun Goo Kang, Sung Yeon Kim, Eui Sil Hong, Sang Wan Kim, Chan Soo Shin, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2005;20(3):216-223.   Published online June 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.3.216
  • 1,652 View
  • 21 Download
AbstractAbstract PDF
BACKGROUND
Prolactin has been identified by gel chromatography to exist is three different forms in human serum; monomeric prolactin(molecular mass 23kDa), big prolactin (molecular mass 50~60 kDa) and big big prolactin, otherwise known as macroprolactin(molecular mass 150~170kDa). The predominance of macroprolactinemia has long been known in idiopathic hyperprolactinemic patients with maintained fertility. In recent reports, 24% of microprolactinoma patients showed no menstrual disturbances, which was suggestive of macroprolactinemia. The purpose of this study was to evaluate: (1) the frequency of macroprolactinemia among idiopathic hyperprolactinemia and prolactinoma patients, (2) the difference in the clinical characteristics between hyperprolactinemia, with and without macroprolactinemia, among idiopathic hyperprolactinemia and prolactinoma patients, and (3) the follow-up prolactin level using the bromocriptine response. METHODS: We retrospectively analyzed the clinical characteristics and prolactin levels in 43 idiopathic hyperprolactinemia and 51 prolactinoma patients with a poor bromocriptine response. Macroprolactinemia was identified by the prolactin recovery of < 40% using the polyethylene glycol(PEG) precipitation test. RESULTS: (1) Of the 43 idiopathic hyperprolactinemia and 51 prolactinoma patients, 17(39.5%) and 9(17.6%), respectively, were macroprolactinemic(P<0.05). (2) Among the idiopathic hyperprolactinemia patients, galactorrhea combined with amenorrhea was significantly less frequent (P<0.05), with the 1- and 2-year follow-up prolactin levels being significantly higher in those with macroprolactinemia than monomeric prolactinemia(P<0.05). (3) Among the prolactinoma patients, amenorrhea was significantly less frequent(P<0.05), but asymptomatic cases were more frequent in those with macroprolactinemia than monomeric prolactinemia(P <0.05). The 1- and 2-year follow-up prolactin levels were significantly higher in those with macroprolactinemia than monomeric prolactinemia(P<0.05). CONCLUSION: The screening of macroprolactinemia should be considered in idiopathic hyperprolactinemia and prolactinoma patients with a poor bromocriptine response
Close layer
High-Dose Hook Effect in Patients with Macroprolactinoma.
Sung Yeon Kim, Chul Gu Park, Young Ju Choi, Eui Sil Hong, Sang Wan Kim, Chan Soo Shin, Hak Chul Jang, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2005;20(2):148-153.   Published online April 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.2.148
  • 1,992 View
  • 20 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Large amounts of antigen may produce false low values on immunoradiometric assays due to the so-called high-dose hook effect. The physicians' awareness of the possibility of the "high-dose hook effect" will prevent preoperative misdiagnosis. The study was designed to identify the frequency and clinical features of patients with pituitary macroadenomas in whom a high-dose PRL hook effect was documented. METHODS: Our retrospective study involved 42 patients with non-functioning pituitary adenomas (tumor diameter >30mm) who underwent transsphenoidal microsurgery from between Jan 1999 to Aug 2004, and 6 patients with non-functioning pituitary adenoma(tumor diameter>30mm) were selected for prospective study from Sep 2003 to Feb 2004. Our retrospective study also involved 13 patients with macroprolactinoma for the comparison of the clinical features. RESULTS: 1) The presence of a high-dose hook effect was retrospectively suggested when the PRL levels increased in 4 out of the 42 patients with non- functioning adenomas(tumor diameter >30mm) after surgery. Post-operative immunohistochemical staining of their pituitary specimens revealed the tumors to be prolactinoma. 2) Prospectively, dilution testing of the specimens obtained before surgery was done in the 6 patients, and one patient presented with a case of the hook effect. The patient's prolactin level was measured at 53.1ng/mL before dilution and this was increased up to 22,600ng/mL upon the 1:1000 dilution. 3) Conclusively, the hook effect was seen in 5 of the 48 patients(10.4%) with non-functioning pituitary adenoma(tumor diameter >30mm) 4) Compared with other 2 patient groups(the macroprolactinoma(N=13) group, and the non-functioning pituitary tumor(N=43) group), the high-dose PRL hook effect is more likely to be observed in male patients with large pituitary tumors. CONCLUSION: In order to avoid the high-dose hook effect, PRL should be assayed at 1:100~1:200 or even higher dilutions of serum from all patients(and especially the male patients) with large pituitary tumors

Citations

Citations to this article as recorded by  
  • Multiple Endocrine Neoplasia Type 1 Presenting with an Invasive Giant Prolactinoma
    Jinhoon Cha, Jin Seo Kim, Jung Suk Han, Yeon Won Park, Min Joo Kim, Yun Hyi Ku, Hong Il Kim
    The Korean Journal of Medicine.2016; 91(3): 300.     CrossRef
Close layer
Diagnostic Value of 24-hours Urinary Total Metanephrine As a Screening Test of Patients with Suspected Pheochromocytoma.
Sang Wan Kim, Kyung Won Kim, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2005;20(1):12-20.   Published online February 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.1.12
  • 1,435 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
A pheochromocytoma is a rare cause of secondary hypertension. Its diagnosis is important as the hypertension is usually curable by resection of the tumor, whereas the condition is potentially lethal if undetected. Biochemical confirmation of excessive catecholamine production is a prerequisite to a definitive diagnosis. Various studies from other countries have indicated that measuring of the urinary metanephrine, using a specific procedure, is the single most reliable screening test for all patients suspected of having a pheochromocytoma. However, the diagnostic value of urinary metanephrine has never been reported in Korea. We investigated the diagnostic value of 24-hours urinary metanephrine in patients with a suspected pheochromocytoma. METHODS: This was a retrospective evaluation study, which included 95 patients with sustained hypertension and paroxysmal symptoms, and 38 patients with asymptomatic adrenal incidentaloma at Seoul National University Hospital, between July 2000 and October 2002. We performed the 24- hour urinary total metanephrine test on all patients. The diagnosis of a pheochromocytoma was applied only when confirmed by pathological analysis of a resected specimen. The possibility of a pheochromocytoma was ruled out when all biochemical tests were normal, which were performed at least in duplicate, or there was no evidence of a mass in abdominal radiological studies or histological verification. We determined the upper reference limit for urinary metanephrine as 1.3mg/day and calculated the sensitivity and specificity of the 24-hour urinary metanephrine test. RESULTS: Seventeen patients were diagnosed with a pheochromocytoma. The total metanephrine measurement had sensitivities and specificities of 82.4 and 73.3% in all the patients, 90.9 and 66.7% in patients with hypertension and paroxysmal symptoms, and 66.7 and 90.6% in patients with adrenal incidentaloma, respectively. CONCLUSION: The urinary total metanephrine measurement had relatively lower sensitivities and specificities than in other countries(sensitivity: 83~100%, specificity: 80~98%). The sensitivity of urinary metanephrine was relatively high in patients with hypertension and paroxysmal symptoms, and the specificity was high in patients with an adrenal incidentaloma. We suggest that normetanephrine and metanephrine should be separately measured, and a reasonable upper reference limit be used. It may also be necessary to measure urinary metanephrine together with urinary catecholamine or VMA to improve the diagnostic value of the urinary metanephrine test.
Close layer
Relationship between Adiponectin, Leptin and Body Fat in Men with Hypogonadism Before and After Testosterone Treatment.
Sang Wan Kim, Joon Ku Kang, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2004;19(5):473-484.   Published online October 1, 2004
  • 1,112 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
Testosterone replacement therapy in men with hypogonadism improves sexual function, decreases body fat, and increases the mass and function of lean muscle. These beneficial effects of testosterone replacement therapy are accompanied by slight lowering of the high density lipoprotein (HDL) cholesterol levels, increase in the hematocrit/hemoglobin ratio and size of the prostate gland. It is presently unknown whether the effect of testosterone on body fat could also reduce the risk of atherosclerotic disease associated with obesity. We investigated the relationship between body fat and blood leptin and adiponectin levels to elucidate the effect of testosterone on body fat metabolism, as well as the effect of testosterone on lipid and bone metabolism. METHODS: We selected 28 men, who were hypogonadal (mean serum testosterone+/-SD, 22.3+/-35.3 ng/dL) due to an organic disease, and them with oral testosterone (testosterone undecanoate) for 12 months. We measured the body composition, serum leptin, plasma adiponectin, biochemical bone markers, bone mineral density, prostate-specific antigen, and serum lipids before and 3, 6 and 12 months after treatment. We analyzed the relationship between body fat and blood leptin and adiponectin levels. RESULTS: The mean serum testosterone concentration reached the subnormal range after 6 months of treatment, which remained for the duration of treatment. The fat mass decreased and muscle mass increased, not within the first 6 months, but principally within 12 months (p<0.05). Although the decrease in the serum leptin level was not statistically significant, there were positive correlations between the leptin level and fat mass before and after 6 months of treatment (p<0.05). The plasma adiponectin did not increase or correlate with body fat parameters. The bone mineral densities of the lumbar spine (L2-L4) and femoral neck did not increased, but the serum osteocalcin and urine N-telopeptide were significantly decreased (p<0.05 and <0.01, respectively). The HDL-cholesterol decreased, principally within the first 6 months (p<0.01), but the total and LDL cholesterols, and the triglycerides remained unchanged during the course of treatment. There was also no change in prostate-specific antigen. CONCLUSION: Twelve months of oral testosterone replacement in men with hypogonadism improved body composition and bone metabolism, but demonstrated subnormal serum testosterone levels, had no effect on the leptin and adiponectin levels and decrease in HDL-cholesterol levels. It will be necessary to examine the long-term effects of testosterone replacement on the incidence of cardiovascular events as well as cardiovascular risk factors in men with hypogonadism
Close layer
Diagnostic Value of 1microgram Rapid ACTH Stimulation Test According to the Timing of Sampling of Serum Cortisol in Patients with Suspected Central Adrenal Insufficiency.
Sang Wan Kim, Young Min Cho, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2004;19(1):33-41.   Published online February 1, 2004
  • 1,241 View
  • 20 Download
AbstractAbstract PDF
BACKGROUND
Traditional testing of the hypothalamic-pituitary-adrenal axis function has essentially relied upon the insulin tolerance test or the metyrapone test(both tests are not only uncomfortable, but are also dangerous). The standard ACTH stimulation test uses an extremely supra-physiologic amount(250f microgram) of ACTH to evaluate a physiological response, which may result in a false normal response. The 1microgram rapid ACTH stimulation test is more physiological and more sensitive than the standard test, but there exist much controversy about when the serum cortisol should be measured or what the most appropriate cut-off point is for normality or whether the 1microgram ACTH commercial solution is needed. The aims of this study were to investigate 1) whether 1microgram of ACTH is an appropriate amount to stimulate the adrenal gland of patients that have suspected central adrenal insufficiency compared with insulin tolerance test(ITT) and 2) the diagnostic value of the 1microgram rapid ACTH stimulation test according to timing of sampling of serum cortisol. METHODS: In order to evaluate the dose-response relationship between ACTH and cortisol, we performed the ITT in 77 patients with suspected central adrenal insufficiency with serial measurements of serum cortisol and plasma ACTH. We drew the blood samples in 10 min intervals between 10 and 60 min after the administration of 1microgram ACTH in 39 patients with central adrenal insufficiency and in 38 pituitary control patients with pituitary. ITT was used to confirm the diseases for the patients of central adrenal insufficiency, but for pituitary control patients, the ITT indicated normality in the patients. Also, all subjects underwent the 250microgram rapid ACTH stimulation test, and we compared the diagnostic value of the 1microgram ACTH stimulation test with the 250microgram test. RESULTS: 1) The plasma ACTH level after the 1microgram ACTH stimulation test, even if it was be assumed as approximately 300pg/mL, was expected to be sufficient enough to stimulate the adrenal cortex normally(serum cortisol levels >18microgram/dL) compared to the plasma ACTH level in the ITT. 2) The sensitivity and specificity of the 1microgram rapid ACTH stimulation test was highest with 92.3% and 84.2%, respectively, when serum cortisol levels were measured at 20, 30, and 40 min after the ACTH injection. The 1microgram rapid ACTH stimulation test was more sensitive than the 250microgram ACTH test(sensitivity: 92.3%, specificity: 71.8%). CONCLUSION: The 1microgram rapid ACTH stimulation test was more sensitive test in patients with suspected central adrenal insufficiency, and blood samples for cortisol levels should be drawn at 20, 30, and 40 min after ACTH administration.
Close layer
Determination of Glucocorticoid Replacement Therapy and Adequate Maintenance Dose in Patients with Secondary Adrenal Insufficiency.
Sang Wan Kim, Hye Seung Jung, Seong Hee Kwon, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2003;18(5):456-464.   Published online October 1, 2003
  • 1,085 View
  • 20 Download
AbstractAbstract PDF
BACKGROUND
Determination of the adequate dose of glucocorticoid replacement therapy, in patients with secondary adrenal insufficiency, is of great importance to avoid the consequences of under or over treatment. The aims of this study were: 1) to assess the value of adrenal cortical function tests in determining whether glucocorticoid replacement should be given, and 2) to investigate the adequate maintenance dose of glucocorticoid in patients with secondary adrenal insufficiency. METHODS: Forty patients, with secondary adrenal insufficiency, confirmed by the insulin-induced hypoglycemia test (IHT), were studied. All subjects underwent basal serum cortisol measurement, IHT and 250 g rapid ACTH stimulation tests (AST). The clinical usefulness of these tests, for the determination of glucocorticoid replacement therapy, was evaluated in patients with secondary adrenal insufficiency. 26 of the 40 patients had received prednisolone (Pd) (5 mg per day) replacement due to symptoms from adrenal insufficiency. The dose of Pd was serially changed from 5 to 3.75, and then to 6.25 mg per day, every 3 month. The measured lipid parameters, serum osteocalcin and urinary N-telopeptide were measured and the quality of life evaluated by the administration of an Addisonian questionnaire, both before and after the dose changes. RESULTS: 1) For all tests, cut-offs were selected that would provide adequate specificity and sensitivity. When the cut-offs were set to provide 95% specificity, the corresponding sensitivitycut-off values, obtained with basal serum cortisol, peak serum cortisol in IHT and AST were: 88.4% <5 microgram/dL, 80.7% <11 microgram/dL and 76.9% <16 microgram/dL. 2) The urinary type I collagen N-telopeptide, total cholesterol, HDL- and LDL-cholesterol levels were significantly increased, and the serum osteocalcin levels significantly decreased when the daily dose of Pd was increased to 6.25 from 3.75 or 5 mg. The LDL-cholesterol levels especially, were significantly increased, even though the change in the Pd from 3.75 to 5 mg per day was subtle. CONCLUSION: The basal cortisol levels, HPA axis tests and the symptoms of patients may be helpful to determine whether prednisolone replacement therapy should be given. It is suggest that an adequate dose of glucocorticoid replacement therapy should be not exceed Pd 5mg per day, so as not to have adverse effects on the bone and lipid metabolisms.
Close layer
Interaction of Pituitary Adenylate Cyclase-Activating Polypeptide and Angiotensin II on Aldosterone Production in Human Adrenocortical H295R Cells.
Seong Yeon Kim, Sang Wan Kim, Young Min Cho, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Bo Youn Cho, Hong Kye Lee
J Korean Endocr Soc. 2003;18(3):272-282.   Published online June 1, 2003
  • 971 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
Evidence is accumulating that aldosterone secretion can be regulated in a paracrine and/or an autocrine manner by several neuropeptides locally released within the adrenal gland. Among neuropeptides, pituitary adenylate cyclase-activating polypeptide (PACAP) is present in high concentration in the human adrenal gland. The purpose of this study was to investigate the action of PACAP and the interaction between PACAP and angiotensin II (AII), the main physiologic aldosterone secretagogue, in aldosterone production in human H295R adrenocortical cells. METHODS: H295R cells were incubated with increasing concentrations of PACAP (10(-11)M~10(-7)M) in the absence or presence of 10(-7)M AII. Aldosterone concentration in the supernatant was determined by RIA. Intracellular cAMP content was measured by RIA and total inositol phosphate (IP) production by anion exchange chromatography. Gene expression of CYP11B2 was studied by RT-PCR. RESULTS: In H295R cells, PACAP stimulated aldosterone production in a dose-dependent manner. Incubation of H295R cells with PACAP in the presence of AII significantly increased aldosterone production, compared with that of PACAP alone. PACAP dose-dependently increased cAMP production, but 10(-7)M AII had no effect on either basal or PACAP-stimulated cAMP production. Total IP production was not affected by PACAP, but was increased by 10(-7)M AII; an increase that was not further increased by addition of PACAP. RT-PCR analysis of H295R cells which were exposed to 10-7M PACAP or 10(-7)M AII showed an increase in CYP11B2 transcript signal. Induction of CYP11B2 mRNA expression in response to treatment with both PACAP and AII was significantly more than that resulting from using PACAP alone. CONCLUSION: The present study demonstrates that PACAP exerts a direct stimulatory effect on aldosterone production through induction of CYP11B2 mRNA expression by adenylate cyclase activation as the main intracellular signal pathway in H295R cells. Furthermore, there may be some additive effects between PACAP and AII on aldosterone production.
Close layer
Calcium Sensing Receptor.
Sang Wan Kim, Chan Soo Shin
J Korean Endocr Soc. 2003;18(3):250-260.   Published online June 1, 2003
  • 865 View
  • 16 Download
AbstractAbstract PDF
No abstract available.
Close layer
A Case of Syndrome of Resistance to Thyroid Hormone Associated with Mutation(M313T) in Thyroid Hormone Receptor Beta Gene.
Jae Kyung Hwang, Kyung Won Kim, Tae Yong Kim, Sang Wan Kim, Young Joo Park, Do Joon Park, Seong Yeon Kim, Hong Kyu Lee, Bo Youn Cho
J Korean Endocr Soc. 2003;18(2):206-213.   Published online April 1, 2003
  • 1,045 View
  • 19 Download
AbstractAbstract PDF
Syndrome of resistance to thyroid hormone(RTH) is inherited by an autosomal dominant trait, and characterized by elevated thyroid hormone levels with reduced responsiveness of the pituitary and peripheral tissues to thyroid hormone action. All of the reported RTH patients have various mutations in the ligand-binding domain coding region of the thyroid hormone receptor beta gene. A 21-year-old man visited our hospital complaining of fatigue. He had mild thyroid goiter and intermittent palpitation. Thyroid function test showed elevated total T3, free T4, and TSH levels. Levels of TSH free a-subunit and basal pituitary hormones, except prolactin, were normal. MRI of the sellar region showed no abnormal finding. TSH response to TRH stimulation was normal, and TSH values to TRH stimulation after T3 suppression revealed partial response. Sequeuce analysis of the thyroid hormone receptor beta gene confirmed a heterozygous missense mutation in exon 9; and the amino acid alteration was a substitution of a threonine(ACG) for a methionine(ATG) at codon313. Sequeuce analysis of the parents showed no mutation.We report the first case of a man with RTH caused by a de novo mutation(M313T) in TRbeta gene, confirmed by sequeuce analysis.
Close layer
The Changes of Expression of Thyroid Specific Antigens in Aging.
Young Joo Park, Eun Shin Park, Tae Yong Kim, Sang Wan Kim, Hyeong Kyu Park, Do Joon Park, Won Bae Kim, Chan Soo Shin, Kyoung Soo Park, Seong Yeon Kim, Sang Chul Park, Hong Kyu Lee, Bo Youn Cho
J Korean Endocr Soc. 2001;16(4-5):457-466.   Published online October 1, 2001
  • 1,020 View
  • 21 Download
AbstractAbstract PDF
BACKGROUND
With the prevalence of serum antithyroglobulin(anti-TG) and antithyroperoxidase(anti-TPO) autoantibodies increasing with age, it has been suggested that changes of thyroid autoimmunity with aging are associated with endemic iodine intake. To understand the mechanism of aging-related increases of thyroid autoimmune response, we investigated the expression of thyroid specific autoantigens of aged phenotype, and compared them with those of young phenotype both in vivo and in vitro. METHODS: Sprague-Dawley rats were sacrificed at 5, 10 and 16 weeks(young), and at 23 months(aged). Their FRTL-5 thyroid cells were harvested at cell passages less than 10(fresh) or more than 30 (aged). The expression of thyroid autoantigens, sodium-iodide symporter(NIS), TSH receptor (TSHR), TG and TPO, were examined by northern blot analysis. To evaluate the effects of iodide, 1mM of NaI was added to the medium for 24 hours, and following incubation the expressions of MHC class I and class II were also examined. RESULTS: The expressions of TPO were markedly increased in the aged rats, and those of TG were moderately. However, NIS and TSHR showed no differences in their expression levels between aged rats and young rats. In vitro, there were no differences in the expressions of TG or TPO, nor of NIS or TSHR, between aged cells and fresh cells. Neither did Iodide exhibit any influence on the expression of MHC molecules in aged cells or fresh cells. CONCLUSION: The expression levels of TPO and TG were increased in aged rats, which may partially explain the mechanism of increasing thyroid autoimmunity with age.
Close layer

Endocrinol Metab : Endocrinology and Metabolism